{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:54:43Z","timestamp":1791377683092,"version":"4.3.2"},"reference-count":543,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>Pulmonary surfactant is a complex lipoprotein mixture secreted into the alveolar lumen by type 2 pneumocytes, which is composed by tens of different lipids (approximately 90% of its entire mass) and surfactant proteins (approximately 10% of the mass). It is crucially involved in maintaining lung homeostasis by reducing the values of alveolar liquid surface tension close to zero at end-expiration, thereby avoiding the alveolar collapse, and assembling a chemical and physical barrier against inhaled pathogens. A deficient amount of surfactant or its functional inactivation is directly linked to a wide range of lung pathologies, including the neonatal respiratory distress syndrome. This paper reviews the main biophysical concepts of surfactant activity and its inactivation mechanisms, and describes the past, present and future roles of surfactant replacement therapy, focusing on the exogenous surfactant preparations marketed worldwide and new formulations under development. The closing section describes the pulmonary surfactant in the context of drug delivery. Thanks to its peculiar composition, biocompatibility, and alveolar spreading capability, the surfactant may work not only as a shuttle to the branched anatomy of the lung for other drugs but also as a modulator for their release, opening to innovative therapeutic avenues for the treatment of several respiratory diseases.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867328666210825110421","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:06:11Z","timestamp":1631775971000},"page":"526-590","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pulmonary Surfactant: A Unique Biomaterial with Life-saving Therapeutic Applications"],"prefix":"10.2174","volume":"29","author":[{"given":"Barbara","family":"Pioselli","sequence":"first","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salomone","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mazzola","sequence":"additional","affiliation":[{"name":"Portfolio Management R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Amidani","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sgarbi","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amadei","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabi","family":"Murgia","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, GAIKER Technology Centre, Zamudio,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Catinella","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Villetti","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[{"name":"Division of Pediatrics and Neonatal Critical Care, Antoine B\u00e9cl\u00e8re Medical Center, APHP, South Paris University Hospitals, Paris, France; Physiopathology and Therapeutic Innovation Unit-U999, South Paris-Saclay University, Paris,France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Carnielli","sequence":"additional","affiliation":[{"name":"Division of Neonatology, G Salesi Women and Children\u2019s Hospital, Polytechnical University of Marche, Ancona,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Civelli","sequence":"additional","affiliation":[{"name":"Preclinical R&amp;D, Chiesi Farmaceutici, Parma,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3181\/00379727-95-23156","volume":"95","author":"Clements J.A.","year":"1957","unstructured":"Clements J.A.; Surface tension of lung extracts. Proc Soc Exp Biol Med 1957,95(1),170-172","journal-title":"Proc Soc Exp Biol Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archpedi.1959.02070010519001","volume":"97","author":"Avery M.E.","year":"1959","unstructured":"Avery M.E.; Mead J.; Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959,97(5, Part 1),517-523","journal-title":"AMA J Dis Child"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fmed.2020.00254","volume":"7","author":"Mirastschijski U.","year":"2020","unstructured":"Mirastschijski U.; Dembinski R.; Maedler K.; Lung surfactant for pulmonary barrier restoration in patients with COVID-19 pneumonia. Front Med (Lausanne) 2020,7,254","journal-title":"Front Med (Lausanne)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000381117","volume":"107","author":"Curstedt T.","year":"2015","unstructured":"Curstedt T.; Halliday H.L.; Speer C.P.; A unique story in neonatal research: the development of a porcine surfactant. Neonatology 2015,107(4),321-329","journal-title":"Neonatology"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(80)90489-4","volume":"1","author":"Fujiwara T.","year":"1980","unstructured":"Fujiwara T.; Maeta H.; Chida S.; Morita T.; Watabe Y.; Abe T.; Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980,1(8159),55-59","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.aanat.2016.09.008","volume":"209","author":"Olmeda B.","year":"2017","unstructured":"Olmeda B.; Mart&#xED;nez-Calle M.; P&#xE9;rez-Gil J.; Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling. Ann Anat 2017,209,78-92","journal-title":"Ann Anat"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000360649","volume":"105","author":"Whitsett J.A.","year":"2014","unstructured":"Whitsett J.A.; The molecular era of surfactant biology. Neonatology 2014,105(4),337-343","journal-title":"Neonatology"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1542\/peds.92.6.768","volume":"92","author":"Egberts J.","year":"1993","unstructured":"Egberts J.; de Winter J.P.; Sedin G.; de Kleine M.J.; Broberger U.; van Bel F.; Curstedt T.; Robertson B.; Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks\u2019 gestation: A randomized trial. Pediatrics 1993,92(6),768-774","journal-title":"Pediatrics"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003063.pub3","author":"Stevens T.P.","year":"2007","unstructured":"Stevens T.P.; Harrington E.W.; Blennow M.; Soll R.F.; Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev [Review].2007(4)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.bbamem.2014.01.028","volume":"1838","author":"Lopez-Rodriguez E.","year":"2014","unstructured":"Lopez-Rodriguez E.; P&#xE9;rez-Gil J.; Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy. Biochim Biophys Acta 2014,1838(6),1568-1585","journal-title":"Biochim Biophys Acta"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.aanat.2016.08.003","volume":"208","author":"Bernhard W.","year":"2016","unstructured":"Bernhard W.; Lung surfactant: Function and composition in the context of development and respiratory physiology. Ann Anat 2016,208,146-150","journal-title":"Ann Anat"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm324","author":"Fahy E.","unstructured":"Fahy E.; Sud M.; Cotter D.; Subramaniam S.; LIPID MAPS online tools for lipid researchNucleic Acids Res, 2007, 35(Web Server issue)(Suppl), W606-12","journal-title":"LIPID MAPS online tools for lipid researchNucleic Acids Res, 2007, 35(Web Server issue)(Suppl), W606-12"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/rcm.844","volume":"16","author":"Pelizzi N.","year":"2002","unstructured":"Pelizzi N.; Catinella S.; Barboso S.; Zanol M.; Different electrospray tandem mass spectrometric approaches for rapid characterization of phospholipid classes of Curosurf, a natural pulmonary surfactant. Rapid Commun Mass Spectrom 2002,16(24),2215-2220","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"12874","DOI":"10.1021\/ja1002185","volume":"132","author":"Garcia-Manyes S.","year":"2010","unstructured":"Garcia-Manyes S.; Redondo-Morata L.; Oncins G.; Sanz F.; Nanomechanics of lipid bilayers: heads or tails? J Am Chem Soc 2010,132(37),12874-12886","journal-title":"J Am Chem Soc"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1194\/jlr.M600451-JLR200","volume":"48","author":"Gille C.","year":"2007","unstructured":"Gille C.; Spring B.; Bernhard W.; Gebhard C.; Basile D.; Lauber K.; Poets C.F.; Orlikowsky T.W.; Differential effect of surfactant and its saturated phosphatidylcholines on human blood macrophages. J Lipid Res 2007,48(2),307-317","journal-title":"J Lipid Res"},{"key":"ref=16","doi-asserted-by":"publisher","unstructured":"Grossmann, G.; Tashiro, K.; Kobayashi, T.; Suzuki, Y.; Matsumoto, Y.; Waseda, Y.; Akino, T.; Curstedt, T.; Robertson, B. Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. J Appl Physiol (1985), 1999, 86(2), 633-640.","DOI":"10.1152\/jappl.1999.86.2.633"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1007\/s00134-008-1224-3","volume":"34","author":"De Luca D.","year":"2008","unstructured":"De Luca D.; Baroni S.; Vento G.; Piastra M.; Pietrini D.; Romitelli F.; Capoluongo E.; Romagnoli C.; Conti G.; Zecca E.; Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med 2008,34(10),1858-1864","journal-title":"Intensive Care Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/ers.12.21","volume":"6","author":"Numata M.","year":"2012","unstructured":"Numata M.; Kandasamy P.; Voelker D.R.; Anionic pulmonary surfactant lipid regulation of innate immunity. Expert Rev Respir Med 2012,6(3),243-246","journal-title":"Expert Rev Respir Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MAJ.0b013e318239c96c","volume":"343","author":"Seeds M.C.","year":"2012","unstructured":"Seeds M.C.; Grier B.L.; Suckling B.N.; Safta A.M.; Long D.L.; Waite B.M.; Morris P.E.; Hite R.D.; Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am J Med Sci 2012,343(6),446-451","journal-title":"Am J Med Sci"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117985","volume":"10","author":"Griese M.","year":"2015","unstructured":"Griese M.; Kirmeier H.G.; Liebisch G.; Rauch D.; St&#xFC;ckler F.; Schmitz G.; Zarbock R.; Surfactant lipidomics in healthy children and childhood interstitial lung disease. PLoS One 2015,10(2)","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1164\/ajrccm.159.2.9805053","volume":"159","author":"Berger A.","year":"1999","unstructured":"Berger A.; Havet N.; Vial D.; Arbibe L.; Dumarey C.; Watson M.L.; Touqui L.; Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. Am J Respir Crit Care Med 1999,159(2),613-618","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0006-2952(97)00328-6","volume":"54","author":"Hidi R.","year":"1997","unstructured":"Hidi R.; Vial D.; Havet N.; Berger A.; Vargaftig B.B.; Touqui L.; Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages. Biochem Pharmacol 1997,54(9),1055-1058","journal-title":"Biochem Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1164\/rccm.200304-467OC","volume":"168","author":"Wu Y-Z.","year":"2003","unstructured":"Wu Y-Z.; Medjane S.; Chabot S.; Kubrusly F.S.; Raw I.; Chignard M.; Touqui L.; Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB. Am J Respir Crit Care Med 2003,168(6),692-699","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"L618","DOI":"10.1152\/ajplung.00274.2004","volume":"288","author":"Hite R.D.","year":"2005","unstructured":"Hite R.D.; Seeds M.C.; Safta A.M.; Jacinto R.B.; Gyves J.I.; Bass D.A.; Waite B.M.; Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction. Am J Physiol Lung Cell Mol Physiol 2005,288(4),L618-L624","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2007.04.035","volume":"568","author":"Blanco O.","year":"2007","unstructured":"Blanco O.; P&#xE9;rez-Gil J.; Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant. Eur J Pharmacol 2007,568(1-3),1-15","journal-title":"Eur J Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1089\/ther.2017.0012","volume":"10","author":"Autilio C.","year":"2020","unstructured":"Autilio C.; Echaide M.; Dell\u2019Orto V.; Perez-Gil J.; De Luca D.; Effect of Whole Body Hypothermia on Surfactant Function When Amniotic Fluid Is Meconium Stained. Ther Hypothermia Temp Manag 2020,10(3),186-189","journal-title":"Ther Hypothermia Temp Manag"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192295","volume":"13","author":"Autilio C.","year":"2018","unstructured":"Autilio C.; Echaide M.; De Luca D.; P&#xE9;rez-Gil J.; Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome. PLoS One 2018,13(2)","journal-title":"PLoS One"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"L143","DOI":"10.1152\/ajplung.1998.274.1.L143","volume":"274","author":"R&#xFC;diger M.","year":"1998","unstructured":"R&#xFC;diger M.; Kolleck I.; Putz G.; Wauer R.R.; Stevens P.; R&#xFC;stow B.; Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures. Am J Physiol 1998,274(1),L143-L148","journal-title":"Am J Physiol"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230229","volume":"15","author":"Guo X.","year":"2020","unstructured":"Guo X.; Luo S.; Amidani D.; Rivetti C.; Pieraccini G.; Pioselli B.; Catinella S.; Murgia X.; Salomone F.; Xu Y.; Dong Y.; Sun B.; In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits. PLoS One 2020,15(3)","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9040080","volume":"9","author":"Yang R.","year":"2019","unstructured":"Yang R.; Zhang Y.; Qian W.; Peng L.; Lin L.; Xu J.; Xie T.; Ji J.; Zhan X.; Shan J.; Surfactant Lipidomics of Alveolar Lavage Fluid in Mice Based on Ultra-High-Performance Liquid Chromatography Coupled to Hybrid Quadrupole-Exactive Orbitrap Mass Spectrometry. Metabolites 2019,9(4)","journal-title":"Metabolites"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000442874","volume":"109","author":"Calkovska A.","year":"2016","unstructured":"Calkovska A.; Linderholm B.; Haegerstrand-Bj&#xF6;rkman M.; Pioselli B.; Pelizzi N.; Johansson J.; Curstedt T.; Phospholipid Composition in Synthetic Surfactants Is Important for Tidal Volumes and Alveolar Stability in Surfactant-Treated Preterm Newborn Rabbits. Neonatology 2016,109(3),177-185","journal-title":"Neonatology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1164\/ajrccm.157.3.9612054","volume":"157","author":"Bunt J.E.","year":"1998","unstructured":"Bunt J.E.; Zimmermann L.J.; Wattimena J.L.; van Beek R.H.; Sauer P.J.; Carnielli V.P.; Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am J Respir Crit Care Med 1998,157(3 Pt 1),810-814","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1164\/ajrccm.161.5.9905088","volume":"161","author":"Torresin M.","year":"2000","unstructured":"Torresin M.; Zimmermann L.J.; Cogo P.E.; Cavicchioli P.; Badon T.; Giordano G.; Zacchello F.; Sauer P.J.; Carnielli V.P.; Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med 2000,161(5),1584-1589","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1465-9921-12-36","volume":"12","author":"Simonato M.","year":"2011","unstructured":"Simonato M.; Baritussio A.; Ori C.; Vedovelli L.; Rossi S.; Dalla Massara L.; Rizzi S.; Carnielli V.P.; Cogo P.E.; Disaturated-phosphatidylcholine and surfactant protein-B turnover in human acute lung injury and in control patients. Respir Res 2011,12(1),36","journal-title":"Respir Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1203\/01.PDR.0000084344.42409.C6","volume":"54","author":"Cogo P.E.","year":"2003","unstructured":"Cogo P.E.; Zimmermann L.J.I.; Meneghini L.; Mainini N.; Bordignon L.; Suma V.; Buffo M.; Carnielli V.P.; Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res 2003,54(5),653-658","journal-title":"Pediatr Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1164\/rccm.2108028","volume":"166","author":"Cogo P.E.","year":"2002","unstructured":"Cogo P.E.; Zimmermann L.J.I.; Rosso F.; Tormena F.; Gamba P.; Verlato G.; Baritussio A.; Carnielli V.P.; Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002,166(2),154-158","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/jms.1979","volume":"46","author":"Vedovelli L.","year":"2011","unstructured":"Vedovelli L.; Baritussio A.; Carnielli V.P.; Simonato M.; Giusti P.; Cogo P.E.; Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry. J Mass Spectrom 2011,46(10),986-992","journal-title":"J Mass Spectrom"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.aanat.2016.05.006","volume":"208","year":"2016","unstructured":"Schr&#xF6;der; Sollfrank; Paulsen; Br&#xE4;uer; Schicht. Recombinant Expression of Surfactant Protein H (SFTA3) in Escherichia Coli. Ann Anat 2016,208,129-134","journal-title":"Ann Anat"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.bpj.2016.06.025","volume":"111","author":"Lopez-Rodriguez E.","year":"2016","unstructured":"Lopez-Rodriguez E.; Pascual A.; Arroyo R.; Floros J.; Perez-Gil J.; Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films. Biophys J 2016,111(3),524-536","journal-title":"Biophys J"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1183\/09031936.00179813","volume":"44","author":"Schicht M.","year":"2014","unstructured":"Schicht M.; Rausch F.; Finotto S.; Mathews M.; Mattil A.; Schubert M.; Koch B.; Traxdorf M.; Bohr C.; Worlitzsch D.; Brandt W.; Garreis F.; Sel S.; Paulsen F.; Br&#xE4;uer L.; SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation. Eur Respir J 2014,44(2),447-456","journal-title":"Eur Respir J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"11998","DOI":"10.1074\/jbc.M109.046243","volume":"285","author":"Wang G.","year":"2010","unstructured":"Wang G.; Guo X.; Diangelo S.; Thomas N.J.; Floros J.; Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem 2010,285(16),11998-12010","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1056\/NEJMra022387","volume":"347","author":"Whitsett J.A.","year":"2002","unstructured":"Whitsett J.A.; Weaver T.E.; Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002,347(26),2141-2148","journal-title":"N Engl J Med"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/532071","volume":"2012","author":"Ariki S.","year":"2012","unstructured":"Ariki S.; Nishitani C.; Kuroki Y.; Diverse functions of pulmonary collectins in host defense of the lung. J Biomed Biotechnol 2012,2012","journal-title":"J Biomed Biotechnol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MOP.0000000000000751","volume":"31","author":"Nogee L.M.","year":"2019","unstructured":"Nogee L.M.; Genetic causes of surfactant protein abnormalities. Curr Opin Pediatr 2019,31(3),330-339","journal-title":"Curr Opin Pediatr"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"E458","DOI":"10.1542\/neo.9-10-e458","volume":"9","author":"Gower W.A.","year":"2008","unstructured":"Gower W.A.; Wert S.E.; Nogee L.M.; Inherited Surfactant Disorders. Neoreviews 2008,9(10),E458-E467","journal-title":"Neoreviews"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1165\/rcmb.2019-0413OC","volume":"63","author":"Autilio C.","year":"2020","unstructured":"Autilio C.; Echaide M.; Shankar-Aguilera S.; Bragado R.; Amidani D.; Salomone F.; P&#xE9;rez-Gil J.; De Luca D.; Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome. Am J Respir Cell Mol Biol 2020,63(3),327-337","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103708","volume":"21","author":"Ca&#xF1;adas O.","year":"2020","unstructured":"Ca&#xF1;adas O.; Olmeda B.; Alonso A.; P&#xE9;rez-Gil J.; Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis. Int J Mol Sci 2020,21(10)","journal-title":"Int J Mol Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2174\/157339631130900006","volume":"10","author":"Ketko A.K.","year":"2014","unstructured":"Ketko A.K.; Donn S.M.; Surfactant-associated proteins: structure, function and clinical implications. Curr Pediatr Rev 2014,10(2),162-167","journal-title":"Curr Pediatr Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.bbamcr.2016.04.028","volume":"1863","year":"2016","unstructured":"Hobi; Giolai; Olmeda; Miklavc; Felder; Walther; Dietl; Frick; P&#xE9;rez-Gil; Haller. A Small Key Unlocks a Heavy Door: The Essential Function of the Small Hydrophobic Proteins SP-B and SP-C to Trigger Adsorption of Pulmonary Surfactant Lamellar Bodies. Biochim Biophys Acta Mol Cell Res 2016,1863(8),2124-2134","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1183\/09031936.04.00105304","volume":"23","author":"B&#xFC;hling F.","year":"2004","unstructured":"B&#xFC;hling F.; Waldburg N.; Reisenauer A.; Heimburg A.; Golpon H.; Welte T.; Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J 2004,23(4),620-628","journal-title":"Eur Respir J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"16178","DOI":"10.1074\/jbc.M312029200","volume":"279","author":"Ueno T.","year":"2004","unstructured":"Ueno T.; Linder S.; Na C-L.; Rice W.R.; Johansson J.; Weaver T.E.; Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004,279(16),16178-16184","journal-title":"J Biol Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00249-012-0858-9","volume":"42","author":"Olmeda B.","year":"2013","unstructured":"Olmeda B.; Garc&#xED;a-&#xC1;lvarez B.; P&#xE9;rez-Gil J.; Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins. Eur Biophys J 2013,42(2-3),209-222","journal-title":"Eur Biophys J"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1039\/C2FD20096A","volume":"161","author":"Bernardino de la Serna J.","year":"2013","unstructured":"Bernardino de la Serna J.; Vargas R.; Picardi V.; Cruz A.; Arranz R.; Valpuesta J.M.; Mateu L.; P&#xE9;rez-Gil J.; Segregated ordered lipid phases and protein-promoted membrane cohesivity are required for pulmonary surfactant films to stabilize and protect the respiratory surface. Faraday Discuss 2013,161,535-548","journal-title":"Faraday Discuss"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.jmb.2020.02.028","volume":"432","author":"Liekkinen J.","year":"2020","unstructured":"Liekkinen J.; Enkavi G.; Javanainen M.; Olmeda B.; P&#xE9;rez-Gil J.; Vattulainen I.; Pulmonary Surfactant Lipid Reorganization Induced by the Adsorption of the Oligomeric Surfactant Protein B Complex. J Mol Biol 2020,432(10),3251-3268","journal-title":"J Mol Biol"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2020.183216","volume":"1862","year":"2020","unstructured":"Martinez-Calle; Prieto; Olmeda; Fedorov; Loura; P&#xE9;rez-Gil, Pulmonary Surfactant Protein SP-B Nanorings Induce the Multilamellar Organization of Surfactant Complexes. Biochim Biophys Acta Biomembr 2020,1862(6)","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.bbamem.2010.03.008","volume":"1798","year":"2010","unstructured":"Olmeda; Vill&#xE9;n; Cruz; Orellana; Perez-Gil., Pulmonary Surfactant Layers Accelerate O2 Diffusion through the Air-Water Interface. Biochim Biophys Acta Biomembr 2010,1798(6),1281-1284","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/joim.12845","volume":"285","author":"Johansson J.","year":"2019","unstructured":"Johansson J.; Curstedt T.; Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases. J Intern Med 2019,285(2),165-186","journal-title":"J Intern Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1021\/bi00185a042","volume":"33","author":"Johansson J.","year":"1994","unstructured":"Johansson J.; Szyperski T.; Curstedt T.; W&#xFC;thrich K.; The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. Biochemistry 1994,33(19),6015-6023","journal-title":"Biochemistry"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1016\/j.bpj.2010.08.070","volume":"99","author":"Baumgart F.","year":"2010","unstructured":"Baumgart F.; Ospina O.L.; Mingarro I.; Rodr&#xED;guez-Crespo I.; P&#xE9;rez-Gil J.; Palmitoylation of pulmonary surfactant protein SP-C is critical for its functional cooperation with SP-B to sustain compression\/expansion dynamics in cholesterol-containing surfactant films. Biophys J 2010,99(10),3234-3243","journal-title":"Biophys J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1165\/rcmb.2010-0347OC","volume":"45","author":"Zhong Q.","year":"2011","unstructured":"Zhong Q.; Zhou B.; Ann D.K.; Minoo P.; Liu Y.; Banfalvi A.; Krishnaveni M.S.; Dubourd M.; Demaio L.; Willis B.C.; Kim K.J.; duBois R.M.; Crandall E.D.; Beers M.F.; Borok Z.; Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. Am J Respir Cell Mol Biol 2011,45(3),498-509","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.physiol.67.040403.101937","volume":"67","author":"Beers M.F.","year":"2005","unstructured":"Beers M.F.; Mulugeta S.; Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 2005,67,663-696","journal-title":"Annu Rev Physiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1600-0854.2011.01223.x","volume":"12","author":"Beers M.F.","year":"2011","unstructured":"Beers M.F.; Hawkins A.; Maguire J.A.; Kotorashvili A.; Zhao M.; Newitt J.L.; Ding W.; Russo S.; Guttentag S.; Gonzales L.; Mulugeta S.; A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling. Traffic 2011,12(9),1196-1210","journal-title":"Traffic"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/17476348.2019.1589372","volume":"13","author":"Walther F.J.","year":"2019","unstructured":"Walther F.J.; Gordon L.M.; Waring A.J.; Advances in synthetic lung surfactant protein technology. Expert Rev Respir Med 2019,13(6),499-501","journal-title":"Expert Rev Respir Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0006-3495(98)77899-3","volume":"74","author":"Ma J.","year":"1998","unstructured":"Ma J.; Koppenol S.; Yu H.; Zografi G.; Effects of a cationic and hydrophobic peptide, KL4, on model lung surfactant lipid monolayers. Biophys J 1998,74(4),1899-1907","journal-title":"Biophys J"},{"key":"ref=65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047631","volume":"7","author":"Seehase M.","year":"2012","unstructured":"Seehase M.; Collins J.J.; Kuypers E.; Jellema R.K.; Ophelders D.R.; Ospina O.L.; Perez-Gil J.; Bianco F.; Garzia R.; Razzetti R.; Kramer B.W.; New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. PLoS One 2012,7(10)","journal-title":"PLoS One"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000276980","volume":"98","author":"Alml&#xE9;n A.","year":"2010","unstructured":"Alml&#xE9;n A.; Walther F.J.; Waring A.J.; Robertson B.; Johansson J.; Curstedt T.; Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits. Neonatology 2010,98(1),91-99","journal-title":"Neonatology"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201926","volume":"13","author":"Ronda L.","year":"2018","unstructured":"Ronda L.; Pioselli B.; Catinella S.; Salomone F.; Marchetti M.; Bettati S.; Quenching of tryptophan fluorescence in a highly scattering solution: Insights on protein localization in a lung surfactant formulation. PLoS One 2018,13(8)","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molliq.2019.111983","year":"2020","unstructured":"Ronda; Faggiano; Paredi; Michielon; Sartor; Raschini; Cavatorta; Sgarbi; Bettati; Mozzarelli, SP-B and SP-C Analogues within CHF5633 Synthetic Surfactant Probed by Fluorescence Labeling. J Mol Liq 2020,298","journal-title":"J Mol Liq"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/pr.2015.123","volume":"78","author":"D\u2019Aronco S.","year":"2015","unstructured":"D\u2019Aronco S.; Simonato M.; Vedovelli L.; Baritussio A.; Verlato G.; Nobile S.; Giorgetti C.; Nespeca M.; Carnielli V.P.; Cogo P.E.; Surfactant protein B and A concentrations are increased in neonatal pneumonia. Pediatr Res 2015,78(4),401-406","journal-title":"Pediatr Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"L257","DOI":"10.1152\/ajplung.00054.2011","volume":"302","author":"Hite R.D.","year":"2012","unstructured":"Hite R.D.; Grier B.L.; Waite B.M.; Veldhuizen R.A.; Possmayer F.; Yao L-J.; Seeds M.C.; Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids. Am J Physiol Lung Cell Mol Physiol 2012,302(2),L257-L265","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/jsbi.1998.4004","volume":"122","author":"Palaniyar N.","year":"1998","unstructured":"Palaniyar N.; Ridsdale R.A.; Holterman C.E.; Inchley K.; Possmayer F.; Harauz G.; Structural changes of surfactant protein A induced by cations reorient the protein on lipid bilayers. J Struct Biol 1998,122(3),297-310","journal-title":"J Struct Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.jmb.2018.03.027","volume":"430","year":"2018","unstructured":"Arroyo; Mart&#xED;n-Gonz&#xE1;lez; Echaide; Jain; Brondyk; Rosenbaum; Moreno-Herrero; P&#xE9;rez-Gil, Supramolecular Assembly of Human Pulmonary Surfactant Protein SP-D. J Mol Biol 2018,430(10),1495-1509","journal-title":"J Mol Biol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI200318650","volume":"111","author":"Wright J.R.","year":"2003","unstructured":"Wright J.R.; Pulmonary surfactant: A front line of lung host defense. J Clin Invest 2003,111(10),1453-1455","journal-title":"J Clin Invest"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0022-2275(20)32127-1","volume":"40","author":"Yu S-H.","year":"1999","unstructured":"Yu S-H.; McCormack F.X.; Voelker D.R.; Possmayer F.; Interactions of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol: roles of SP-A domains. J Lipid Res 1999,40(5),920-929","journal-title":"J Lipid Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.bbamem.2008.05.003","volume":"1778","author":"P&#xE9;rez-Gil J.","year":"2008","unstructured":"P&#xE9;rez-Gil J.; Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta 2008,1778(7-8),1676-1695","journal-title":"Biochim Biophys Acta"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2020.151670","volume":"235","author":"Arroyo R.","year":"2021","unstructured":"Arroyo R.; Grant S.N.; Gouwens K.R.; Miller D.M.; Kingma P.S.; Evaluation of recombinant human SP-D in the rat premature lung model. Ann Anat 2021,235","journal-title":"Ann Anat"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI3236","volume":"102","author":"Arbibe L.","year":"1998","unstructured":"Arbibe L.; Koumanov K.; Vial D.; Rougeot C.; Faure G.; Havet N.; Longacre S.; Vargaftig B.B.; B&#xE9;r&#xE9;ziat G.; Voelker D.R.; Wolf C.; Touqui L.; Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998,102(6),1152-1160","journal-title":"J Clin Invest"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"v","DOI":"10.1016\/j.coi.2017.05.001","volume":"44","author":"Colonna M.","year":"2017","unstructured":"Colonna M.; Editorial Overview: Sense and react: how the innate immune system detects threats and generates protective responses. Curr Opin Immunol 2017,44,v-vii","journal-title":"Curr Opin Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.01.008","volume":"25","author":"Hoffmann J.","year":"2013","unstructured":"Hoffmann J.; Akira S.; Innate immunity. Curr Opin Immunol 2013,25(1),1-3","journal-title":"Curr Opin Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.aanat.2017.03.002","volume":"211","author":"Vieira F.","year":"2017","unstructured":"Vieira F.; Kung J.W.; Bhatti F.; Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Ann Anat 2017,211,184-201","journal-title":"Ann Anat"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.imbio.2010.07.003","volume":"216","author":"Steinstraesser L.","year":"2011","unstructured":"Steinstraesser L.; Kraneburg U.; Jacobsen F.; Al-Benna S.; Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 2011,216(3),322-333","journal-title":"Immunobiology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-981-15-1580-4_4","volume":"1204","author":"Murugaiah V.","year":"2020","unstructured":"Murugaiah V.; Tsolaki A.G.; Kishore U.; Collectins: Innate Immune Pattern Recognition Molecules. Adv Exp Med Biol 2020,1204,75-127","journal-title":"Adv Exp Med Biol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/17471060600736829","volume":"2","author":"Haagsman H.P.","year":"2009","unstructured":"Haagsman H.P.; Hogenkamp A.; Van Eijk M.; Collectin-Mediated Innate Immune Defense in the Lung. J Organ Dysfunct 2009,2(4),230-236","journal-title":"J Organ Dysfunct"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fimmu.2020.00394","volume":"11","author":"Kishore U.","year":"2020","unstructured":"Kishore U.; Bulla R.; Madan T.; Editorial: Odyssey of Surfactant Proteins SP-A and SP-D: Innate Immune Surveillance Molecules. Front Immunol 2020,11,394","journal-title":"Front Immunol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/157489110791233559","volume":"5","author":"Awasthi S.","year":"2010","unstructured":"Awasthi S.; Surfactant protein (SP)-A and SP-D as antimicrobial and immunotherapeutic agents. Recent Pat Antiinfect Drug Discov 2010,5(2),115-123","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fimmu.2018.01126","volume":"9","author":"Kaur A.","year":"2018","unstructured":"Kaur A.; Riaz M.S.; Murugaiah V.; Varghese P.M.; Singh S.K.; Kishore U.; A Recombinant Fragment of Human Surfactant Protein D induces Apoptosis in Pancreatic Cancer Cell Lines via Fas-Mediated Pathway. Front Immunol 2018,9,1126","journal-title":"Front Immunol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev.immunol.21.120601.140954","volume":"21","author":"Holmskov U.","year":"2003","unstructured":"Holmskov U.; Thiel S.; Jensenius J.C.; Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003,21(1),547-578","journal-title":"Annu Rev Immunol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"L958","DOI":"10.1152\/ajplung.1998.274.6.L958","volume":"274","author":"Hartshorn K.L.","year":"1998","unstructured":"Hartshorn K.L.; Crouch E.; White M.R.; Colamussi M.L.; Kakkanatt A.; Tauber B.; Shepherd V.; Sastry K.N.; Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998,274(6),L958-L969","journal-title":"Am J Physiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1164\/ajrccm.158.2.9709111","volume":"158","author":"Wang J.Y.","year":"1998","unstructured":"Wang J.Y.; Shieh C.C.; You P.F.; Lei H.Y.; Reid K.B.; Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med 1998,158(2),510-518","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1046\/j.1365-2249.1996.d01-838.x","volume":"106","author":"Wang J.Y.","year":"1996","unstructured":"Wang J.Y.; Kishore U.; Lim B.L.; Strong P.; Reid K.B.; Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol 1996,106(2),367-373","journal-title":"Clin Exp Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/01902140490276294","volume":"30","author":"Bufler P.","year":"2004","unstructured":"Bufler P.; Schikor D.; Schmidt B.; Griese M.; Cytokine stimulation by Pseudomonas aeruginosa--strain variation and modulation by pulmonary surfactant. Exp Lung Res 2004,30(3),163-179","journal-title":"Exp Lung Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"6002","DOI":"10.1128\/IAI.72.10.6002-6011.2004","volume":"72","author":"Atochina E.N.","year":"2004","unstructured":"Atochina E.N.; Beck J.M.; Preston A.M.; Haczku A.; Tomer Y.; Scanlon S.T.; Fusaro T.; Casey J.; Hawgood S.; Gow A.J.; Beers M.F.; Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: Attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 2004,72(10),6002-6011","journal-title":"Infect Immun"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-9255-10-2","volume":"10","author":"Liu J.","year":"2013","unstructured":"Liu J.; Hu F.; Wang G.; Zhou Q.; Ding G.; Lipopolysaccharide-induced expression of surfactant proteins A1 and A2 in human renal tubular epithelial cells. J Inflamm (Lond) 2013,10(1),2","journal-title":"J Inflamm (Lond)"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.4049\/jimmunol.0903867","volume":"184","author":"Lee D-C.","year":"2010","unstructured":"Lee D-C.; Romero R.; Kim C.J.; Chaiworapongsa T.; Tarca A.L.; Lee J.; Suh Y-L.; Mazaki-Tovi S.; Vaisbuch E.; Mittal P.; Draghici S.; Erez O.; Kusanovic J.P.; Hassan S.S.; Kim J.S.; Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy. J Immunol 2010,184(11),6479-6491","journal-title":"J Immunol"},{"key":"ref=95","first-page":"979","volume":"33","author":"Luo J.M.","year":"2008","unstructured":"Luo J.M.; Liu Z.Q.; Eugene C.Y.; Overexpression of pulmonary surfactant protein A like molecules in inflammatory bowel disease tissues. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2008,33(11),979-986","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1167\/iovs.07-0201","volume":"48","author":"Br&#xE4;uer L.","year":"2007","unstructured":"Br&#xE4;uer L.; Kindler C.; J&#xE4;ger K.; Sel S.; N&#xF6;lle B.; Pleyer U.; Ochs M.; Paulsen F.P.; Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Invest Ophthalmol Vis Sci 2007,48(9),3945-3953","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074412","volume":"8","author":"Schob S.","year":"2013","unstructured":"Schob S.; Schicht M.; Sel S.; Stiller D.; Kekul&#xE9; A.S.; Paulsen F.; Maronde E.; Br&#xE4;uer L.; Br&#xE4;uer L.; The detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS. PLoS One 2013,8(9)","journal-title":"PLoS One"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1164\/rccm.201701-0225OC","volume":"196","author":"Qaseem A.S.","year":"2017","unstructured":"Qaseem A.S.; Singh I.; Pathan A.A.; Layhadi J.A.; Parkin R.; Alexandra F.; Durham S.R.; Kishore U.; Shamji M.H.; A Recombinant Fragment of Human Surfactant Protein D Suppresses Basophil Activation and T-Helper Type 2 and B-Cell Responses in Grass Pollen-induced Allergic Inflammation. Am J Respir Crit Care Med 2017,196(12),1526-1534","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.bpj.2015.10.022","volume":"109","author":"Cerrada A.","year":"2015","unstructured":"Cerrada A.; Haller T.; Cruz A.; P&#xE9;rez-Gil J.; Pneumocytes Assemble Lung Surfactant as Highly Packed\/Dehydrated States with Optimal Surface Activity. Biophys J 2015,109(11),2295-2306","journal-title":"Biophys J"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/rr36","volume":"2","author":"Fehrenbach H.","year":"2001","unstructured":"Fehrenbach H.; Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001,2(1),33-46","journal-title":"Respir Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0022-2275(20)41642-6","volume":"32","author":"Schmitz G.","year":"1991","unstructured":"Schmitz G.; M&#xFC;ller G.; Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991,32(10),1539-1570","journal-title":"J Lipid Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"L113","DOI":"10.1152\/ajplung.1991.260.2.L113","volume":"260","author":"Young S.L.","year":"1991","unstructured":"Young S.L.; Fram E.K.; Spain C.L.; Larson E.W.; Development of type II pneumocytes in rat lung. Am J Physiol 1991,260(2 Pt 1),L113-L122","journal-title":"Am J Physiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1152\/physiol.00006.2010","volume":"25","author":"Perez-Gil J.","year":"2010","unstructured":"Perez-Gil J.; Weaver T.E.; Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 2010,25(3),132-141","journal-title":"Physiology (Bethesda)"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00441-016-2520-9","volume":"367","author":"Lopez-Rodriguez E.","year":"2017","unstructured":"Lopez-Rodriguez E.; Gay-Jordi G.; Mucci A.; Lachmann N.; Serrano-Mollar A.; Lung surfactant metabolism: early in life, early in disease and target in cell therapy. Cell Tissue Res 2017,367(3),721-735","journal-title":"Cell Tissue Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"L259","DOI":"10.1152\/ajplung.00112.2007","volume":"293","author":"Andreeva A.V.","year":"2007","unstructured":"Andreeva A.V.; Kutuzov M.A.; Voyno-Yasenetskaya T.A.; Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 2007,293(2),L259-L271","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00441-016-2554-z","volume":"367","author":"Beers M.F.","year":"2017","unstructured":"Beers M.F.; Mulugeta S.; The biology of the ABCA3 lipid transporter in lung health and disease. Cell Tissue Res 2017,367(3),481-493","journal-title":"Cell Tissue Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"28174","DOI":"10.1074\/jbc.M110.106518","volume":"285","author":"Ravasio A.","year":"2010","unstructured":"Ravasio A.; Olmeda B.; Bertocchi C.; Haller T.; P&#xE9;rez-Gil J.; Lamellar bodies form solid three-dimensional films at the respiratory air-liquid interface. J Biol Chem 2010,285(36),28174-28182","journal-title":"J Biol Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/humu.23416","volume":"39","author":"Schindlbeck U.","year":"2018","unstructured":"Schindlbeck U.; Wittmann T.; H&#xF6;ppner S.; Kinting S.; Liebisch G.; Hegermann J.; Griese M.; ABCA3 missense mutations causing surfactant dysfunction disorders have distinct cellular phenotypes. Hum Mutat 2018,39(6),841-850","journal-title":"Hum Mutat"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1074\/jbc.M611767200","volume":"282","author":"Ban N.","year":"2007","unstructured":"Ban N.; Matsumura Y.; Sakai H.; Takanezawa Y.; Sasaki M.; Arai H.; Inagaki N.; ABCA3 as a lipid transporter in pulmonary surfactant biogenesis. J Biol Chem 2007,282(13),9628-9634","journal-title":"J Biol Chem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"23811","DOI":"10.1074\/jbc.M703927200","volume":"282","author":"Cheong N.","year":"2007","unstructured":"Cheong N.; Zhang H.; Madesh M.; Zhao M.; Yu K.; Dodia C.; Fisher A.B.; Savani R.C.; Shuman H.; ABCA3 is critical for lamellar body biogenesis in vivo. J Biol Chem 2007,282(33),23811-23817","journal-title":"J Biol Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1388-1981(01)00104-4","volume":"1531","author":"Osanai K.","year":"2001","unstructured":"Osanai K.; Mason R.J.; Voelker D.R.; Pulmonary Surfactant Phosphatidylcholine Transport Bypasses the Brefeldin A Sensitive Compartment of Alveolar Type II Cells. Biochim Biophys Acta Mol Cell Biol Lipids 2001,1531(3),222-229","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00441-020-03232-7","volume":"381","author":"Osanai K.","year":"2020","unstructured":"Osanai K.; Mizuno S.; Toga H.; Takahashi K.; Trafficking of newly synthesized surfactant protein B to the lamellar body in alveolar type II cells. Cell Tissue Res 2020,381(3),427-438","journal-title":"Cell Tissue Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1096\/fj.201701462RR","volume":"32","author":"Mart&#xED;nez-Calle M.","year":"2018","unstructured":"Mart&#xED;nez-Calle M.; Olmeda B.; Dietl P.; Frick M.; P&#xE9;rez-Gil J.; Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells. FASEB J 2018,32(8),4600-4611","journal-title":"FASEB J"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1165\/rcmb.2002-0149OC","volume":"29","author":"Foster C.D.","year":"2003","unstructured":"Foster C.D.; Zhang P.X.; Gonzales L.W.; Guttentag S.H.; In vitro surfactant protein B deficiency inhibits lamellar body formation. Am J Respir Cell Mol Biol 2003,29(2),259-266","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev.physiol.63.1.555","volume":"63","author":"Weaver T.E.","year":"2001","unstructured":"Weaver T.E.; Conkright J.J.; Function of surfactant proteins B and C. Annu Rev Physiol 2001,63(1),555-578","journal-title":"Annu Rev Physiol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"L51","DOI":"10.1152\/ajplung.00066.2010","volume":"299","author":"Fisher A.B.","year":"2010","unstructured":"Fisher A.B.; Dodia C.; Ruckert P.; Tao J-Q.; Bates S.R.; Pathway to lamellar bodies for surfactant protein A. Am J Physiol Lung Cell Mol Physiol 2010,299(1),L51-L58","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1095-6433(01)00320-8","volume":"129","author":"Rooney S.A.","year":"2001","unstructured":"Rooney S.A.; Regulation of surfactant secretion. Comp Biochem Physiol A Mol Integr Physiol 2001,129(1),233-243","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1183\/09031936.02.00211202","volume":"19","author":"Brackenbury A.M.","year":"2002","unstructured":"Brackenbury A.M.; Malloy J.L.; McCaig L.A.; Yao L.J.; Veldhuizen R.A.W.; Lewis J.F.; Evaluation of alveolar surfactant aggregates In vitro and in vivo. Eur Respir J 2002,19(1),41-46","journal-title":"Eur Respir J"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000444891","volume":"109","author":"Carnielli V.P.","year":"2016","unstructured":"Carnielli V.P.; Giorgetti C.; Simonato M.; Vedovelli L.; Cogo P.; Neonatal Respiratory Diseases in the Newborn Infant: Novel Insights from Stable Isotope Tracer Studies. Neonatology 2016,109(4),325-333","journal-title":"Neonatology"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1165\/ajrcmb.26.1.4570","volume":"26","author":"Ochs M.","year":"2002","unstructured":"Ochs M.; Johnen G.; M&#xFC;ller K-M.; Wahlers T.; Hawgood S.; Richter J.; Brasch F.; Intracellular and intraalveolar localization of surfactant protein A (SP-A) in the parenchymal region of the human lung. Am J Respir Cell Mol Biol 2002,26(1),91-98","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"9594","DOI":"10.1073\/pnas.93.18.9594","volume":"93","author":"Korfhagen T.R.","year":"1996","unstructured":"Korfhagen T.R.; Bruno M.D.; Ross G.F.; Huelsman K.M.; Ikegami M.; Jobe A.H.; Wert S.E.; Stripp B.R.; Morris R.E.; Glasser S.W.; Bachurski C.J.; Iwamoto H.S.; Whitsett J.A.; Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996,93(18),9594-9599","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0022-2275(20)37577-5","volume":"37","author":"Wang Z.","year":"1996","unstructured":"Wang Z.; Hall S.B.; Notter R.H.; Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. J Lipid Res 1996,37(4),790-798","journal-title":"J Lipid Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bpj.2012.11.014","volume":"104","author":"Parra E.","year":"2013","unstructured":"Parra E.; Alcaraz A.; Cruz A.; Aguilella V.M.; P&#xE9;rez-Gil J.; Hydrophobic pulmonary surfactant proteins SP-B and SP-C induce pore formation in planar lipid membranes: evidence for proteolipid pores. Biophys J 2013,104(1),146-155","journal-title":"Biophys J"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1164\/rccm.200308-1107OC","volume":"169","author":"Ochs M.","year":"2004","unstructured":"Ochs M.; Nyengaard J.R.; Jung A.; Knudsen L.; Voigt M.; Wahlers T.; Richter J.; Gundersen H.J.G.; The number of alveoli in the human lung. Am J Respir Crit Care Med 2004,169(1),120-124","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1164\/ajrccm\/140.2.385","volume":"140","author":"Donahoe M.","year":"1989","unstructured":"Donahoe M.; Rogers R.M.; Wilson D.O.; Pennock B.E.; Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989,140(2),385-391","journal-title":"Am Rev Respir Dis"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.bbamem.2008.03.021","volume":"1778","author":"Zuo Y.Y.","year":"2008","unstructured":"Zuo Y.Y.; Veldhuizen R.A.W.; Neumann A.W.; Petersen N.O.; Possmayer F.; Current perspectives in pulmonary surfactant--inhibition, enhancement and evaluation. Biochim Biophys Acta 2008,1778(10),1947-1977","journal-title":"Biochim Biophys Acta"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0959-440X(02)00352-4","volume":"12","author":"Piknova B.","year":"2002","unstructured":"Piknova B.; Schram V.; Hall S.B.; Pulmonary surfactant: phase behavior and function. Curr Opin Struct Biol 2002,12(4),487-494","journal-title":"Curr Opin Struct Biol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1016\/j.bbamem.2012.05.024","volume":"1818","author":"Casals C.","year":"2012","unstructured":"Casals C.; Ca&#xF1;adas O.; Role of lipid ordered\/disordered phase coexistence in pulmonary surfactant function. Biochim Biophys Acta 2012,1818(11),2550-2562","journal-title":"Biochim Biophys Acta"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbamem.2014.10.009","volume":"1848","year":"2015","unstructured":"Roldan; Goormaghtigh; P&#xE9;rez-Gil; Garcia-Alvarez. Palmitoylation as a Key Factor to Modulate SP-C-Lipid Interactions in Lung Surfactant Membrane Multilayers. Biochim Biophys Acta Biomembr 2015,1848(1),184-191","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1165\/rcmb.2019-0358OC","volume":"62","author":"Ruwisch J.","year":"2020","unstructured":"Ruwisch J.; Sehlmeyer K.; Roldan N.; Garcia-Alvarez B.; Perez-Gil J.; Weaver T.E.; Ochs M.; Knudsen L.; Lopez-Rodriguez E.; Air Space Distension Precedes Spontaneous Fibrotic Remodeling and Impaired Cholesterol Metabolism in the Absence of Surfactant Protein C. Am J Respir Cell Mol Biol 2020,62(4),466-478","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"503","DOI":"10.21037\/atm.2019.09.33","volume":"7","author":"Yehya N.","year":"2019","unstructured":"Yehya N.; Lessons learned in acute respiratory distress syndrome from the animal laboratory. Ann Transl Med 2019,7(19),503","journal-title":"Ann Transl Med"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"L64","DOI":"10.1152\/ajplung.90640.2008","volume":"297","author":"Glasser S.W.","year":"2009","unstructured":"Glasser S.W.; Witt T.L.; Senft A.P.; Baatz J.E.; Folger D.; Maxfield M.D.; Akinbi H.T.; Newton D.A.; Prows D.R.; Korfhagen T.R.; Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2009,297(1),L64-L72","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fped.2017.00186","volume":"5","author":"Ricci F.","year":"2017","unstructured":"Ricci F.; Salomone F.; Kuypers E.; Ophelders D.; Nikiforou M.; Willems M.; Krieger T.; Murgia X.; H&#xFC;tten M.; Kramer B.W.; Bianco F.; In vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome. Front Pediatr 2017,5,186","journal-title":"Front Pediatr"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.aanat.2016.11.015","volume":"210","author":"Beers M.F.","year":"2017","unstructured":"Beers M.F.; Knudsen L.; Tomer Y.; Maronn J.; Zhao M.; Ochs M.; Mulugeta S.; Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene. Ann Anat 2017,210,135-146","journal-title":"Ann Anat"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fmed.2015.00049","volume":"2","author":"Jobe A.H.","year":"2015","unstructured":"Jobe A.H.; Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease. Front Med (Lausanne) 2015,2,49","journal-title":"Front Med (Lausanne)"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"L543","DOI":"10.1152\/ajplung.00011.2003","volume":"285","author":"Melton K.R.","year":"2003","unstructured":"Melton K.R.; Nesslein L.L.; Ikegami M.; Tichelaar J.W.; Clark J.C.; Whitsett J.A.; Weaver T.E.; SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003,285(3),L543-L549","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1073\/pnas.101500298","volume":"98","author":"Glasser S.W.","year":"2001","unstructured":"Glasser S.W.; Burhans M.S.; Korfhagen T.R.; Na C-L.; Sly P.D.; Ross G.F.; Ikegami M.; Whitsett J.A.; Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001,98(11),6366-6371","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000047041","volume":"76","author":"Weaver T.E.","year":"1999","unstructured":"Weaver T.E.; Beck D.C.; Use of knockout mice to study surfactant protein structure and function. Biol Neonate 1999,76(Suppl. 1),15-18","journal-title":"Biol Neonate"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"F443","DOI":"10.1136\/archdischild-2018-315413","volume":"104","author":"Autilio C.","year":"2019","unstructured":"Autilio C.; P&#xE9;rez-Gil J.; Understanding the principle biophysics concepts of pulmonary surfactant in health and disease. Arch Dis Child Fetal Neonatal Ed 2019,104(4),F443-F451","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chemphyslip.2014.09.002","volume":"185","author":"Parra E.","year":"2015","unstructured":"Parra E.; P&#xE9;rez-Gil J.; Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films. Chem Phys Lipids 2015,185,153-175","journal-title":"Chem Phys Lipids"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41598-020-58248-4","volume":"10","author":"Echaide M.","year":"2020","unstructured":"Echaide M.; Autilio C.; L&#xF3;pez-Rodr&#xED;guez E.; Cruz A.; P&#xE9;rez-Gil J.; In vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition. Sci Rep 2020,10(1),1385","journal-title":"Sci Rep"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.bbamem.2011.03.006","volume":"1808","author":"Zhang H.","year":"2011","unstructured":"Zhang H.; Fan Q.; Wang Y.E.; Neal C.R.; Zuo Y.Y.; Comparative study of clinical pulmonary surfactants using atomic force microscopy. Biochim Biophys Acta 2011,1808(7),1832-1842","journal-title":"Biochim Biophys Acta"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1529\/biophysj.108.130732","volume":"95","author":"Zuo Y.Y.","year":"2008","unstructured":"Zuo Y.Y.; Tadayyon S.M.; Keating E.; Zhao L.; Veldhuizen R.A.W.; Petersen N.O.; Amrein M.W.; Possmayer F.; Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: Albumin-inhibited pulmonary surfactant films and the effect of SP-A. Biophys J 2008,95(6),2779-2791","journal-title":"Biophys J"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0006-3495(04)74106-5","volume":"86","author":"Cruz A.","year":"2004","unstructured":"Cruz A.; V&#xE1;zquez L.; V&#xE9;lez M.; P&#xE9;rez-Gil J.; Effect of pulmonary surfactant protein SP-B on the micro- and nanostructure of phospholipid films. Biophys J 2004,86(1 Pt 1),308-320","journal-title":"Biophys J"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0006-3495(01)75688-3","volume":"81","author":"Takamoto D.Y.","year":"2001","unstructured":"Takamoto D.Y.; Lipp M.M.; von Nahmen A.; Lee K.Y.C.; Waring A.J.; Zasadzinski J.A.; Interaction of lung surfactant proteins with anionic phospholipids. Biophys J 2001,81(1),153-169","journal-title":"Biophys J"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bbamem.2011.12.007","volume":"1818","author":"Keating E.","year":"2012","unstructured":"Keating E.; Zuo Y.Y.; Tadayyon S.M.; Petersen N.O.; Possmayer F.; Veldhuizen R.A.W.; A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant. Biochim Biophys Acta 2012,1818(5),1225-1234","journal-title":"Biochim Biophys Acta"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1021\/la702612p","volume":"24","author":"Mao G.","year":"2008","unstructured":"Mao G.; Desai J.; Flach C.R.; Mendelsohn R.; Structural characterization of the monolayer-multilayer transition in a pulmonary surfactant model: IR studies of films transferred at continuously varying surface pressures. Langmuir 2008,24(5),2025-2034","journal-title":"Langmuir"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00249-004-0446-8","volume":"34","author":"Wang L.","year":"2005","unstructured":"Wang L.; Cai P.; Galla H-J.; He H.; Flach C.R.; Mendelsohn R.; Monolayer-multilayer transitions in a lung surfactant model: IR reflection-absorption spectroscopy and atomic force microscopy. Eur Biophys J 2005,34(3),243-254","journal-title":"Eur Biophys J"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1529\/biophysj.106.099762","volume":"93","author":"Keating E.","year":"2007","unstructured":"Keating E.; Rahman L.; Francis J.; Petersen A.; Possmayer F.; Veldhuizen R.; Petersen N.O.; Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. Biophys J 2007,93(4),1391-1401","journal-title":"Biophys J"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0006-3495(00)76297-7","volume":"79","author":"Bourdos N.","year":"2000","unstructured":"Bourdos N.; Kollmer F.; Benninghoven A.; Ross M.; Sieber M.; Galla H.J.; Analysis of lung surfactant model systems with time-of-flight secondary ion mass spectrometry. Biophys J 2000,79(1),357-369","journal-title":"Biophys J"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bpj.2020.06.033","volume":"119","author":"Xu L.","year":"2020","unstructured":"Xu L.; Yang Y.; Zuo Y.Y.; Atomic Force Microscopy Imaging of Adsorbed Pulmonary Surfactant Films. Biophys J 2020,119(4),756-766","journal-title":"Biophys J"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jpeds.2016.11.057","volume":"182","author":"Autilio C.","year":"2017","unstructured":"Autilio C.; Echaide M.; Benachi A.; Marfaing-Koka A.; Capoluongo E.D.; P&#xE9;rez-Gil J.; De Luca D.; A Noninvasive Surfactant Adsorption Test Predicting the Need for Surfactant Therapy in Preterm Infants Treated with Continuous Positive Airway Pressure. J Pediatr 2017,182,66-73.e1","journal-title":"J Pediatr"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1183\/09031936.00117714","volume":"44","author":"De Luca D.","year":"2014","unstructured":"De Luca D.; V&#xE1;zquez-S&#xE1;nchez S.; Minucci A.; Echaide M.; Piastra M.; Conti G.; Capoluongo E.D.; P&#xE9;rez-Gil J.; Effect of whole body hypothermia on inflammation and surfactant function in asphyxiated neonates. Eur Respir J 2014,44(6),1708-1710","journal-title":"Eur Respir J"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1152\/nips.01438.2003","volume":"18","author":"Daniels C.B.","year":"2003","unstructured":"Daniels C.B.; Orgeig S.; Pulmonary surfactant: the key to the evolution of air breathing. News Physiol Sci 2003,18,151-157","journal-title":"News Physiol Sci"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/ajrcmb.25.6.4616","volume":"25","author":"Bernhard W.","year":"2001","unstructured":"Bernhard W.; Hoffmann S.; Dombrowsky H.; Rau G.A.; Kamlage A.; Kappler M.; Haitsma J.J.; Freihorst J.; von der Hardt H.; Poets C.F.; Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol 2001,25(6),725-731","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12931-019-0979-0","volume":"20","author":"Tridente A.","year":"2019","unstructured":"Tridente A.; De Martino L.; De Luca D.; Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes. Respir Res 2019,20(1),28","journal-title":"Respir Res"},{"key":"ref=157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010249.pub2","volume":"2015","author":"Singh N.","year":"2015","unstructured":"Singh N.; Halliday H.L.; Stevens T.P.; Suresh G.; Soll R.; Rojas-Reyes M.X.; Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2015,2015(12)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1529\/biophysj.104.051201","volume":"87","author":"Alonso C.","year":"2004","unstructured":"Alonso C.; Alig T.; Yoon J.; Bringezu F.; Warriner H.; Zasadzinski J.A.; More than a monolayer: relating lung surfactant structure and mechanics to composition. Biophys J 2004,87(6),4188-4202","journal-title":"Biophys J"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"L277","DOI":"10.1152\/ajplung.00199.2001","volume":"282","author":"King D.M.","year":"2002","unstructured":"King D.M.; Wang Z.; Palmer H.J.; Holm B.A.; Notter R.H.; Bulk shear viscosities of endogenous and exogenous lung surfactants. Am J Physiol Lung Cell Mol Physiol 2002,282(2),L277-L284","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/cphy.c150003","volume":"6","author":"Orgeig S.","year":"2015","unstructured":"Orgeig S.; Morrison J.L.; Daniels C.B.; Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments. Compr Physiol 2015,6(1),363-422","journal-title":"Compr Physiol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/icb\/38.2.305","volume":"38","year":"1998","unstructured":"C. B.; ORGEIG, S.; WOOD, P. G.; SULLIVAN, L. C.; LOPATKO, O. V.; SMITS, A. W. The Changing State of Surfactant Lipids: New Insights from Ancient Animals. Am Zool 1998,38(2),305-320","journal-title":"Am Zool"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.1021\/la201482n","volume":"27","author":"Zhang H.","year":"2011","unstructured":"Zhang H.; Wang Y.E.; Fan Q.; Zuo Y.Y.; On the low surface tension of lung surfactant. Langmuir 2011,27(13),8351-8358","journal-title":"Langmuir"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/pr.2011.78","volume":"71","author":"Zhang H.","year":"2012","unstructured":"Zhang H.; Wang Y.E.; Neal C.R.; Zuo Y.Y.; Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant. Pediatr Res 2012,71(4 Pt 1),316-323","journal-title":"Pediatr Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1529\/biophysj.107.106310","volume":"93","author":"Leonenko Z.","year":"2007","unstructured":"Leonenko Z.; Gill S.; Baoukina S.; Monticelli L.; Doehner J.; Gunasekara L.; Felderer F.; Rodenstein M.; Eng L.M.; Amrein M.; An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film. Biophys J 2007,93(2),674-683","journal-title":"Biophys J"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1164\/rccm.200912-1818OC","volume":"181","author":"Sato A.","year":"2010","unstructured":"Sato A.; Whitsett J.A.; Scheule R.K.; Ikegami M.; Surfactant protein-d inhibits lung inflammation caused by ventilation in premature newborn lambs. Am J Respir Crit Care Med 2010,181(10),1098-1105","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000492974","volume":"11","author":"Watson A.","year":"2019","unstructured":"Watson A.; Phipps M.J.S.; Clark H.W.; Skylaris C-K.; Madsen J.; Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins. J Innate Immun 2019,11(1),13-28","journal-title":"J Innate Immun"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biocel.2016.11.003","volume":"81","year":"2016","unstructured":"Nathan; Taytard; Duquesnoy; Thouvenin; Corvol; Amselem; Clement. Surfactant Protein A: A Key Player in Lung Homeostasis. Int J Biochem Cell Biol 2016,81,151-155","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4049\/jimmunol.1501032","volume":"197","author":"Minutti C.M.","year":"2016","unstructured":"Minutti C.M.; Garc&#xED;a-Fojeda B.; S&#xE1;enz A.; de Las Casas-Engel M.; Guillamat-Prats R.; de Lorenzo A.; Serrano-Mollar A.; Corb&#xED; &#xC1;.L.; Casals C.; Surfactant Protein A Prevents IFN-&#x3B3;\/IFN-&#x3B3; Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages. J Immunol 2016,197(2),590-598","journal-title":"J Immunol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1183\/09031936.97.10091967","volume":"10","author":"Sun B.","year":"1997","unstructured":"Sun B.; Curstedt T.; Lindgren G.; Franz&#xE9;n B.; Alaiya A.A.; Calkovsk&#xE1; A.; Robertson B.; Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur Respir J 1997,10(9),1967-1974","journal-title":"Eur Respir J"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12931-019-1267-8","volume":"21","author":"Foligno S.","year":"2020","unstructured":"Foligno S.; De Luca D.; Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes. Respir Res 2020,21(1),8","journal-title":"Respir Res"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.colsurfb.2019.03.020","volume":"178","author":"Thai L.P.A.","year":"2019","unstructured":"Thai L.P.A.; Mousseau F.; Oikonomou E.K.; Berret J.F.; On the rheology of pulmonary surfactant: Effects of concentration and consequences for the surfactant replacement therapy. Colloids Surf B Biointerfaces 2019,178,337-345","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0009-3084(01)00150-5","volume":"112","author":"King D.M.","year":"2001","unstructured":"King D.M.; Wang Z.; Kendig J.W.; Palmer H.J.; Holm B.A.; Notter R.H.; Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions. Chem Phys Lipids 2001,112(1),11-19","journal-title":"Chem Phys Lipids"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbamem.2009.01.005","volume":"1788","author":"Lu K.W.","year":"2009","unstructured":"Lu K.W.; P&#xE9;rez-Gil J.; Taeusch H.; Kinematic viscosity of therapeutic pulmonary surfactants with added polymers. Biochim Biophys Acta 2009,1788(3),632-637","journal-title":"Biochim Biophys Acta"},{"key":"ref=174","first-page":"531","volume":"40","author":"Antonova N.","year":"2003","unstructured":"Antonova N.; Todorov R.; Exerowa D.; Rheological behavior and parameters of the In vitro model of lung surfactant systems: the role of the main phospholipid component. Biorheology 2003,40(5),531-543","journal-title":"Biorheology"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0009-3084(99)00042-0","volume":"100","author":"Tolle A.","year":"1999","unstructured":"Tolle A.; Meier W.; Greune G.; Rudiger M.; Peter Hofmann K.; Rustow B.; Plasmalogens Reduce the Viscosity of a Surfactant-like Phospholipid Monolayer. Chem Phys Lipids 1999,100(1-2),81-87","journal-title":"Chem Phys Lipids"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"L379","DOI":"10.1152\/ajplung.00176.2004","volume":"288","author":"R&#xFC;diger M.","year":"2005","unstructured":"R&#xFC;diger M.; T&#xF6;lle A.; Meier W.; R&#xFC;stow B.; Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am J Physiol Lung Cell Mol Physiol 2005,288(2),L379-L383","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/rr86","volume":"2","author":"G&#xFC;nther A.","year":"2001","unstructured":"G&#xFC;nther A.; Ruppert C.; Schmidt R.; Markart P.; Grimminger F.; Walmrath D.; Seeger W.; Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001,2(6),353-364","journal-title":"Respir Res"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1183\/09031936.05.00085805","volume":"26","author":"Huang W.","year":"2005","unstructured":"Huang W.; McCaig L.A.; Veldhuizen R.A.W.; Yao L-J.; Lewis J.F.; Mechanisms responsible for surfactant changes in sepsis-induced lung injury. Eur Respir J 2005,26(6),1074-1079","journal-title":"Eur Respir J"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1128\/IAI.69.2.758-764.2001","volume":"69","author":"Wright T.W.","year":"2001","unstructured":"Wright T.W.; Notter R.H.; Wang Z.; Harmsen A.G.; Gigliotti F.; Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect Immun 2001,69(2),758-764","journal-title":"Infect Immun"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000153095","volume":"95","author":"Hamvas A.","year":"2009","unstructured":"Hamvas A.; Heins H.B.; Guttentag S.H.; Wegner D.J.; Trusgnich M.A.; Bennet K.W.; Yang P.; Carlson C.S.; An P.; Cole F.S.; Developmental and genetic regulation of human surfactant protein B in vivo. Neonatology 2009,95(2),117-124","journal-title":"Neonatology"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1369\/jhc.6A6962.2006","volume":"55","author":"Stahlman M.T.","year":"2007","unstructured":"Stahlman M.T.; Besnard V.; Wert S.E.; Weaver T.E.; Dingle S.; Xu Y.; von Zychlin K.; Olson S.J.; Whitsett J.A.; Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 2007,55(1),71-83","journal-title":"J Histochem Cytochem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1111\/j.1440-1843.2006.00803.x","volume":"11","author":"Ikegami M.","year":"2006","unstructured":"Ikegami M.; Surfactant catabolism. Respirology 2006,11(Suppl.),S24-S27","journal-title":"Respirology"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"L1266","DOI":"10.1152\/ajplung.2001.280.6.L1266","volume":"280","author":"Gurel O.","year":"2001","unstructured":"Gurel O.; Ikegami M.; Chroneos Z.C.; Jobe A.H.; Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2001,280(6),L1266-L1272","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.2000.278.6.L1164","volume":"278","author":"Reed J.A.","year":"2000","unstructured":"Reed J.A.; Ikegami M.; Robb L.; Begley C.G.; Ross G.; Whitsett J.A.; Distinct changes in pulmonary surfactant homeostasis in common &#x3B2;-chain- and GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol 2000,278(6),L1164-L1171","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"L650","DOI":"10.1152\/ajplung.1996.270.4.L650","volume":"270","author":"Ikegami M.","year":"1996","unstructured":"Ikegami M.; Ueda T.; Hull W.; Whitsett J.A.; Mulligan R.C.; Dranoff G.; Jobe A.H.; Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol 1996,270(4 Pt 1),L650-L658","journal-title":"Am J Physiol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41467-018-05491-z","volume":"9","author":"McCarthy C.","year":"2018","unstructured":"McCarthy C.; Lee E.; Bridges J.P.; Sallese A.; Suzuki T.; Woods J.C.; Bartholmai B.J.; Wang T.; Chalk C.; Carey B.C.; Arumugam P.; Shima K.; Tarling E.J.; Trapnell B.C.; Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis. Nat Commun 2018,9(1),3127","journal-title":"Nat Commun"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/jmg.2010.082586","volume":"48","author":"Tanaka T.","year":"2011","unstructured":"Tanaka T.; Motoi N.; Tsuchihashi Y.; Tazawa R.; Kaneko C.; Nei T.; Yamamoto T.; Hayashi T.; Tagawa T.; Nagayasu T.; Kuribayashi F.; Ariyoshi K.; Nakata K.; Morimoto K.; Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet 2011,48(3),205-209","journal-title":"J Med Genet"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1183\/09031936.00090610","volume":"37","author":"Suzuki T.","year":"2011","unstructured":"Suzuki T.; Maranda B.; Sakagami T.; Catellier P.; Couture C-Y.; Carey B.C.; Chalk C.; Trapnell B.C.; Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations. Eur Respir J 2011,37(1),201-204","journal-title":"Eur Respir J"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0925-4439(98)00066-0","volume":"1408","author":"Weaver T.E.","year":"1998","unstructured":"Weaver T.E.; Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998,1408(2-3),173-179","journal-title":"Biochim Biophys Acta"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/bi036218q","volume":"43","author":"Li J.","year":"2004","unstructured":"Li J.; Ikegami M.; Na C-L.; Hamvas A.; Espinassous Q.; Chaby R.; Nogee L.M.; Weaver T.E.; Johansson J.; N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry 2004,43(13),3891-3898","journal-title":"Biochemistry"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1165\/ajrcmb.22.3.3645","volume":"22","author":"Beers M.F.","year":"2000","unstructured":"Beers M.F.; Hamvas A.; Moxley M.A.; Gonzales L.W.; Guttentag S.H.; Solarin K.O.; Longmore W.J.; Nogee L.M.; Ballard P.L.; Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol 2000,22(3),380-391","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1165\/ajrcmb.26.6.f241","volume":"26","author":"Nogee L.M.","year":"2002","unstructured":"Nogee L.M.; Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell Mol Biol 2002,26(6),641-644","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1651-2227.2006.00188.x","volume":"96","author":"Wegner D.J.","year":"2007","unstructured":"Wegner D.J.; Hertzberg T.; Heins H.B.; Elmberger G.; MacCoss M.J.; Carlson C.S.; Nogee L.M.; Cole F.S.; Hamvas A.; A major deletion in the surfactant protein-B gene causing lethal respiratory distress. Acta Paediatr 2007,96(4),516-520","journal-title":"Acta Paediatr"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ppul.22971","volume":"49","author":"Avital A.","year":"2014","unstructured":"Avital A.; Hevroni A.; Godfrey S.; Cohen S.; Maayan C.; Nusair S.; Nogee L.M.; Springer C.; Natural history of five children with surfactant protein C mutations and interstitial lung disease. Pediatr Pulmonol 2014,49(11),1097-1105","journal-title":"Pediatr Pulmonol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1378\/chest.09-0790","volume":"137","author":"Crossno P.F.","year":"2010","unstructured":"Crossno P.F.; Polosukhin V.V.; Blackwell T.S.; Johnson J.E.; Markin C.; Moore P.E.; Worrell J.A.; Stahlman M.T.; Phillips J.A.; Loyd J.E.; Cogan J.D.; Lawson W.E.; Identification of early interstitial lung disease in an individual with genetic variations in ABCA3 and SFTPC. Chest 2010,137(4),969-973","journal-title":"Chest"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.200508016","volume":"172","author":"Bridges J.P.","year":"2006","unstructured":"Bridges J.P.; Xu Y.; Na C-L.; Wong H.R.; Weaver T.E.; Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 2006,172(3),395-407","journal-title":"J Cell Biol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jpeds.2004.10.028","volume":"146","author":"Cameron H.S.","year":"2005","unstructured":"Cameron H.S.; Somaschini M.; Carrera P.; Hamvas A.; Whitsett J.A.; Wert S.E.; Deutsch G.; Nogee L.M.; A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005,146(3),370-375","journal-title":"J Pediatr"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ppul.23493","volume":"52","author":"Litao M.K.S.","year":"2017","unstructured":"Litao M.K.S.; Hayes D.; Chiwane S.; Nogee L.M.; Kurland G.; Guglani L.; A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy. Pediatr Pulmonol 2017,52(1),57-68","journal-title":"Pediatr Pulmonol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.med.60.041807.123500","volume":"61","author":"Whitsett J.A.","year":"2010","unstructured":"Whitsett J.A.; Wert S.E.; Weaver T.E.; Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 2010,61,105-119","journal-title":"Annu Rev Med"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1067\/mpd.2001.114545","volume":"139","author":"Amin R.S.","year":"2001","unstructured":"Amin R.S.; Wert S.E.; Baughman R.P.; Tomashefski J.F.; Nogee L.M.; Brody A.S.; Hull W.M.; Whitsett J.A.; Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001,139(1),85-92","journal-title":"J Pediatr"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.gene.2013.11.015","volume":"534","author":"Gon&#xE7;alves J.P.","year":"2014","unstructured":"Gon&#xE7;alves J.P.; Pinheiro L.; Costa M.; Silva A.; Gon&#xE7;alves A.; Pereira A.; Novel ABCA3 mutations as a cause of respiratory distress in a term newborn. Gene 2014,534(2),417-420","journal-title":"Gene"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"34503","DOI":"10.1074\/jbc.M600071200","volume":"281","author":"Matsumura Y.","year":"2006","unstructured":"Matsumura Y.; Ban N.; Ueda K.; Inagaki N.; Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem 2006,281(45),34503-34514","journal-title":"J Biol Chem"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bbrc.2007.05.219","volume":"359","author":"Hammel M.","year":"2007","unstructured":"Hammel M.; Michel G.; Hoefer C.; Klaften M.; M&#xFC;ller-H&#xF6;cker J.; de Angelis M.H.; Holzinger A.; Targeted inactivation of the murine Abca3 gene leads to respiratory failure in newborns with defective lamellar bodies. Biochem Biophys Res Commun 2007,359(4),947-951","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1016\/j.febslet.2007.05.078","volume":"581","author":"Matsumura Y.","year":"2007","unstructured":"Matsumura Y.; Sakai H.; Sasaki M.; Ban N.; Inagaki N.; ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells. FEBS Lett 2007,581(17),3139-3144","journal-title":"FEBS Lett"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1164\/rccm.200509-1535OC","volume":"174","author":"Brasch F.","year":"2006","unstructured":"Brasch F.; Schimanski S.; M&#xFC;hlfeld C.; Barlage S.; Langmann T.; Aslanidis C.; Boettcher A.; Dada A.; Schroten H.; Mildenberger E.; Prueter E.; Ballmann M.; Ochs M.; Johnen G.; Griese M.; Schmitz G.; Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006,174(5),571-580","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=206","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.568303","volume":"11","author":"Jouza M.","year":"2020","unstructured":"Jouza M.; Jimramovsky T.; Sloukova E.; Pecl J.; Seehofnerova A.; Jezova M.; Urik M.; Kunovsky L.; Slaba K.; Stourac P.; Klincova M.; Hubacek J.A.; Jabandziev P.; A Newly Observed Mutation of the ABCA3 Gene Causing Lethal Respiratory Failure of a Full-Term Newborn: A Case Report. Front Genet 2020,11","journal-title":"Front Genet"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1164\/rccm.200703-393OC","volume":"176","author":"Deutsch G.H.","year":"2007","unstructured":"Deutsch G.H.; Young L.R.; Deterding R.R.; Fan L.L.; Dell S.D.; Bean J.A.; Brody A.S.; Nogee L.M.; Trapnell B.C.; Langston C.; Albright E.A.; Askin F.B.; Baker P.; Chou P.M.; Cool C.M.; Coventry S.C.; Cutz E.; Davis M.M.; Dishop M.K.; Galambos C.; Patterson K.; Travis W.D.; Wert S.E.; White F.V.; Diffuse lung disease in young children: Application of a novel classification scheme. Am J Respir Crit Care Med 2007,176(11),1120-1128","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/CS20080068","volume":"116","author":"Boggaram V.","year":"2009","unstructured":"Boggaram V.; Thyroid transcription factor-1 (TTF-1\/Nkx2.1\/TITF1) gene regulation in the lung. Clin Sci (Lond) 2009,116(1),27-35","journal-title":"Clin Sci (Lond)"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.12-2502","volume":"144","author":"Hamvas A.","year":"2013","unstructured":"Hamvas A.; Deterding R.R.; Wert S.E.; White F.V.; Dishop M.K.; Alfano D.N.; Halbower A.C.; Planer B.; Stephan M.J.; Uchida D.A.; Williames L.D.; Rosenfeld J.A.; Lebel R.R.; Young L.R.; Cole F.S.; Nogee L.M.; Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. Chest 2013,144(3),794-804","journal-title":"Chest"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1002\/humu.21183","volume":"31","author":"Guillot L.","year":"2010","unstructured":"Guillot L.; Carr&#xE9; A.; Szinnai G.; Castanet M.; Tron E.; Jaubert F.; Broutin I.; Counil F.; Feldmann D.; Clement A.; Polak M.; Epaud R.; NKX2-1 mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in &#x201C;Brain-Lung-Thyroid Syndrome&#x201D;. Hum Mutat 2010,31(2),E1146-E1162","journal-title":"Hum Mutat"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jpeds.2004.04.011","volume":"145","author":"Doyle D.A.","year":"2004","unstructured":"Doyle D.A.; Gonzalez I.; Thomas B.; Scavina M.; Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. J Pediatr 2004,145(2),190-193","journal-title":"J Pediatr"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jpeds.2017.01.017","volume":"184","year":"2017","unstructured":"Eldridge; Zhang; Faro; Sweet; Eghtesady; Hamvas; Cole; Wambach. Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism. J Pediatr 2017,184,157-164","journal-title":"J Pediatr"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cis.2020.102244","year":"2020","unstructured":"Wang; Liu; Zeng. Interactions of Particulate Matter and Pulmonary Surfactant: Implications for Human Health. Adv Colloid Interface Sci 2020,284","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=214","author":"Kim J.","unstructured":"Kim J.; Koca H.K.; Viklund E.; Olin A.; ERS International Congress, Madrid, SpainSeptember 28-October 02, 20192019."},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1165\/rcmb.2013-0523OC","volume":"51","author":"Agarwal A.R.","year":"2014","unstructured":"Agarwal A.R.; Yin F.; Cadenas E.; Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol 2014,51(2),284-293","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bbamem.2008.11.021","volume":"1788","author":"Stenger P.C.","year":"2009","unstructured":"Stenger P.C.; Alonso C.; Zasadzinski J.A.; Waring A.J.; Jung C.L.; Pinkerton K.E.; Environmental tobacco smoke effects on lung surfactant film organization. Biochim Biophys Acta 2009,1788(2),358-370","journal-title":"Biochim Biophys Acta"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1357-4310(99)01470-7","volume":"5","author":"Touqui L.","year":"1999","unstructured":"Touqui L.; Arbibe L.; A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today 1999,5(6),244-249","journal-title":"Mol Med Today"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(17)30214-X","volume":"5","author":"De Luca D.","year":"2017","unstructured":"De Luca D.; van Kaam A.H.; Tingay D.G.; Courtney S.E.; Danhaive O.; Carnielli V.P.; Zimmermann L.J.; Kneyber M.C.J.; Tissieres P.; Brierley J.; Conti G.; Pillow J.J.; Rimensberger P.C.; The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med 2017,5(8),657-666","journal-title":"Lancet Respir Med"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1378\/chest.14-2454","volume":"147","author":"Calfee C.S.","year":"2015","unstructured":"Calfee C.S.; Janz D.R.; Bernard G.R.; May A.K.; Kangelaris K.N.; Matthay M.A.; Ware L.B.; Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 2015,147(6),1539-1548","journal-title":"Chest"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00134-014-3589-9","volume":"41","author":"Moussa M.D.","year":"2015","unstructured":"Moussa M.D.; Santonocito C.; Fagnoul D.; Donadello K.; Pradier O.; Gaussem P.; De Backer D.; Vincent J-L.; Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells. Intensive Care Med 2015,41(2),231-238","journal-title":"Intensive Care Med"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"Calfee C.S.","year":"2014","unstructured":"Calfee C.S.; Delucchi K.; Parsons P.E.; Thompson B.T.; Ware L.B.; Matthay M.A.; Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014,2(8),611-620","journal-title":"Lancet Respir Med"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"L950","DOI":"10.1152\/ajplung.00210.2004","volume":"288","author":"Lee J.W.","year":"2005","unstructured":"Lee J.W.; Gonzalez R.F.; Chapin C.J.; Busch J.; Fineman J.R.; Gutierrez J.A.; Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2005,288(5),L950-L957","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1165\/ajrcmb.22.3.3788","volume":"22","author":"Glumoff V.","year":"2000","unstructured":"Glumoff V.; V&#xE4;yrynen O.; Kangas T.; Hallman M.; Degree of lung maturity determines the direction of the interleukin-1- induced effect on the expression of surfactant proteins. Am J Respir Cell Mol Biol 2000,22(3),280-288","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/atm.2017.12.18","volume":"6","author":"Herrero R.","year":"2018","unstructured":"Herrero R.; Sanchez G.; Lorente J.A.; New insights into the mechanisms of pulmonary edema in acute lung injury. Ann Transl Med 2018,6(2),32","journal-title":"Ann Transl Med"},{"key":"ref=225","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1986.60.2.532","author":"Rennard S. I.","unstructured":"Rennard S. I.; Basset G.; Lecossier D.; O\u2019Donnell K. M.; Pinkston P.; Martin P. G.; Crystal R. G.; Estimation of Volume of Epithelial Lining Fluid Recovered by Lavage Using Urea as Marker of Dilution J Appl Physiol (1985), 1986, 60(2), 532-538","journal-title":"Estimation of Volume of Epithelial Lining Fluid Recovered by Lavage Using Urea as Marker of Dilution J Appl Physiol (1985), 1986, 60(2), 532-538"},{"key":"ref=226","first-page":"718","volume":"124","author":"Sprung C.L.","year":"1981","unstructured":"Sprung C.L.; Rackow E.C.; Fein I.A.; Jacob A.I.; Isikoff S.K.; The spectrum of pulmonary edema: differentiation of cardiogenic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis 1981,124(6),718-722","journal-title":"Am Rev Respir Dis"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/ajrccm\/136.4.957","volume":"136","author":"Sprung C.L.","year":"1987","unstructured":"Sprung C.L.; Long W.M.; Marcial E.H.; Schein R.M.; Parker R.E.; Shomer T.; Brigham K.L.; Distribution of proteins in pulmonary edema. The value of fractional concentrations. Am Rev Respir Dis 1987,136(4),957-963","journal-title":"Am Rev Respir Dis"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbamem.2007.10.027","volume":"1778","author":"Gunasekara L.","year":"2008","unstructured":"Gunasekara L.; Schoel W.M.; Sch&#xFC;rch S.; Amrein M.W.; A comparative study of mechanisms of surfactant inhibition. Biochim Biophys Acta 2008,1778(2),433-444","journal-title":"Biochim Biophys Acta"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"L1088","DOI":"10.1152\/ajplung.00420.2002","volume":"286","author":"Ishizaka A.","year":"2004","unstructured":"Ishizaka A.; Matsuda T.; Albertine K.H.; Koh H.; Tasaka S.; Hasegawa N.; Kohno N.; Kotani T.; Morisaki H.; Takeda J.; Nakamura M.; Fang X.; Martin T.R.; Matthay M.A.; Hashimoto S.; Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004,286(6),L1088-L1094","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbamem.2009.12.010","volume":"1798","author":"Zasadzinski J.A.","year":"2010","unstructured":"Zasadzinski J.A.; Stenger P.C.; Shieh I.; Dhar P.; Overcoming rapid inactivation of lung surfactant: Analogies between competitive adsorption and colloid stability. Biochim Biophys Acta 2010,1798(4),801-828","journal-title":"Biochim Biophys Acta"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"12072","DOI":"10.1039\/c2sm25937k","volume":"8","author":"Georgiev G.A.","year":"2012","unstructured":"Georgiev G.A.; Vassilieff C.; Jordanova A.; Tsanova A.; Lalchev Z.; Foam Film Study of Albumin Inhibited Lung Surfactant Preparations: Effect of Added Hydrophilic PolymersElectronic Supplementary Information (ESI). Available Soft Matter 2012,8(48),12072-12079","journal-title":"Available Soft Matter"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bpj.2012.08.024","volume":"103","author":"L&#xF3;pez-Rodr&#xED;guez E.","year":"2012","unstructured":"L&#xF3;pez-Rodr&#xED;guez E.; Ospina O.L.; Echaide M.; Taeusch H.W.; P&#xE9;rez-Gil J.; Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer. Biophys J 2012,103(7),1451-1459","journal-title":"Biophys J"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1529\/biophysj.105.062646","volume":"89","author":"Zasadzinski J.A.","year":"2005","unstructured":"Zasadzinski J.A.; Alig T.F.; Alonso C.; Bernardino de la Serna J.; Perez-Gil J.; Taeusch H.W.; Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory. Biophys J 2005,89(3),1621-1629","journal-title":"Biophys J"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1096\/fj.09-142646","volume":"24","author":"S&#xE1;enz A.","year":"2010","unstructured":"S&#xE1;enz A.; L&#xF3;pez-S&#xE1;nchez A.; Mojica-L&#xE1;zaro J.; Mart&#xED;nez-Caro L.; Nin N.; Bagatolli L.A.; Casals C.; Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A. FASEB J 2010,24(10),3662-3673","journal-title":"FASEB J"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1021\/acsabm.9b00623","volume":"2","author":"Lee H-R.","year":"2019","unstructured":"Lee H-R.; Park S.; Choi S.Q.; Irremovable Blood Stain in Lung: Air-to-Interface Transport of Albumin and Its Mechanical Response to Biaxial Compression\/Expansion. ACS Appl Bio Mater 2019,2(12),5551-5558","journal-title":"ACS Appl Bio Mater"},{"key":"ref=236","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2017.0895","volume":"15","author":"Williams I.","year":"2018","unstructured":"Williams I.; Squires T.M.; Evolution and mechanics of mixed phospholipid fibrinogen monolayers. J R Soc Interface 2018,15(141)","journal-title":"J R Soc Interface"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s00396-014-3319-4","volume":"292","author":"Devraj R.","year":"2014","unstructured":"Devraj R.; Nag K.; Nahak P.; Manna K.; Fritzen-Garcia M.; Thompson D.; Makino K.; Ohshima H.; Nakahara H.; Shibata O.; Impairing Effect of Fibrinogen on the Mono-\/Bi-Layer Form of Bovine Lung Surfactant. Colloid Polym Sci 2014,292(11),2765-2774","journal-title":"Colloid Polym Sci"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jcis.2010.08.058","volume":"352","author":"Nag K.","year":"2010","unstructured":"Nag K.; Vidyashankar S.; Devraj R.; Fritzen Garcia M.; Panda A.K.; Physicochemical studies on the interaction of serum albumin with pulmonary surfactant extract in films and bulk bilayer phase. J Colloid Interface Sci 2010,352(2),456-464","journal-title":"J Colloid Interface Sci"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.resp.2007.02.001","volume":"157","author":"Nag K.","year":"2007","unstructured":"Nag K.; Hillier A.; Parsons K.; Garcia M.F.; Interactions of serum with lung surfactant extract in the bronchiolar and alveolar airway models. Respir Physiol Neurobiol 2007,157(2-3),411-424","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbrep.2016.06.009","volume":"7","author":"Milos S.","year":"2016","unstructured":"Milos S.; Hiansen J.Q.; Banaschewski B.; Zuo Y.Y.; Yao L-J.; McCaig L.A.; Lewis J.; Yamashita C.M.; Veldhuizen R.A.W.; The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury. Biochem Biophys Rep 2016,7,180-187","journal-title":"Biochem Biophys Rep"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jcf.2017.04.015","volume":"16","author":"Gunasekara L.","year":"2017","unstructured":"Gunasekara L.; Al-Saiedy M.; Green F.; Pulmonary Surfactant Dysfunction in Pediatric Cystic Fibrosis: Mechanisms and Reversal with a Lipid-Sequestering Drug. Journal of Cystic Fibros is 2017,16(5),565-572","journal-title":"Journal of Cystic Fibros is"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/pr.2015.265","volume":"79","author":"Kopincova J.","year":"2016","unstructured":"Kopincova J.; Calkovska A.; Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms. Pediatr Res 2016,79(4),514-521","journal-title":"Pediatr Res"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"E3592","DOI":"10.1073\/pnas.1701239114","volume":"114","author":"Andersson J.M.","year":"2017","unstructured":"Andersson J.M.; Grey C.; Larsson M.; Ferreira T.M.; Sparr E.; Effect of cholesterol on the molecular structure and transitions in a clinical-grade lung surfactant extract. Proc Natl Acad Sci USA 2017,114(18),E3592-E3601","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"L117","DOI":"10.1152\/ajplung.00218.2009","volume":"298","author":"Vockeroth D.","year":"2010","unstructured":"Vockeroth D.; Gunasekara L.; Amrein M.; Possmayer F.; Lewis J.F.; Veldhuizen R.A.W.; Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2010,298(1),L117-L125","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.bbamem.2017.03.015","volume":"1859","author":"Echaide M.","year":"2017","unstructured":"Echaide M.; Autilio C.; Arroyo R.; Perez-Gil J.; Restoring pulmonary surfactant membranes and films at the respiratory surface. Biochim Biophys Acta Biomembr 2017,1859(9 Pt B),1725-1739","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bpj.2010.12.3715","volume":"100","author":"Lopez-Rodriguez E.","year":"2011","unstructured":"Lopez-Rodriguez E.; Echaide M.; Cruz A.; Taeusch H.W.; Perez-Gil J.; Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids. Biophys J 2011,100(3),646-655","journal-title":"Biophys J"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00134-008-1321-3","volume":"35","author":"De Luca D.","year":"2009","unstructured":"De Luca D.; Minucci A.; Zecca E.; Piastra M.; Pietrini D.; Carnielli V.P.; Zuppi C.; Tridente A.; Conti G.; Capoluongo E.D.; Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration. Intensive Care Med 2009,35(2),321-326","journal-title":"Intensive Care Med"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1021\/la061870i","volume":"23","author":"Ma G.","year":"2007","unstructured":"Ma G.; Allen H.C.; Condensing effect of palmitic acid on DPPC in mixed Langmuir monolayers. Langmuir 2007,23(2),589-597","journal-title":"Langmuir"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbamem.2005.10.014","volume":"1720","author":"Hite R.D.","year":"2005","unstructured":"Hite R.D.; Seeds M.C.; Jacinto R.B.; Grier B.L.; Waite B.M.; Bass D.A.; Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis. Biochim Biophys Acta 2005,1720(1-2),14-21","journal-title":"Biochim Biophys Acta"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","volume":"1831","author":"Sevastou I.","year":"2013","unstructured":"Sevastou I.; Kaffe E.; Mouratis M.A.; Aidinis V.; Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)\/LPC and ATX\/LPA axes. Biochim Biophys Acta 2013,1831(1),42-60","journal-title":"Biochim Biophys Acta"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2431-11-101","volume":"11","author":"De Luca D.","year":"2011","unstructured":"De Luca D.; Capoluongo E.; Rigo V.; Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: A multicentre translational study. BMC Pediatr 2011,11,101","journal-title":"BMC Pediatr"},{"key":"ref=252","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/pr.2011.733","volume":"70","author":"de Luca D.","year":"2011","unstructured":"de Luca D.; Carnielli V.; Minucci A.; Tripodi D.; Piastra M.; Pietrini D.; Capoluongo E.D.; Conti G.; Poster presentations: lung, respiration. Pediatric Research 2011,70,508","journal-title":"Pediatric Research"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.bbagen.2018.01.008","volume":"1862","author":"Al-Saiedy M.","year":"2018","unstructured":"Al-Saiedy M.; Pratt R.; Lai P.; Kerek E.; Joyce H.; Prenner E.; Green F.; Ling C.C.; Veldhuizen R.; Ghandorah S.; Amrein M.; Dysfunction of pulmonary surfactant mediated by phospholipid oxidation is cholesterol-dependent. Biochim Biophys Acta, Gen Subj 2018,1862(4),1040-1049","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1529\/biophysj.105.073106","volume":"90","author":"Rodr&#xED;guez-Capote K.","year":"2006","unstructured":"Rodr&#xED;guez-Capote K.; Manzanares D.; Haines T.; Possmayer F.; Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J 2006,90(8),2808-2821","journal-title":"Biophys J"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/PL00007561","volume":"175","author":"Putman E.","year":"1997","unstructured":"Putman E.; van Golde L.M.; Haagsman H.P.; Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 1997,175(2),75-103","journal-title":"Lung"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/10715760600571248","volume":"40","author":"Starosta V.","year":"2006","unstructured":"Starosta V.; Griese M.; Oxidative damage to surfactant protein D in pulmonary diseases. Free Radic Res 2006,40(4),419-425","journal-title":"Free Radic Res"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1194\/jlr.M300360-JLR200","volume":"45","author":"Kuzmenko A.I.","year":"2004","unstructured":"Kuzmenko A.I.; Wu H.; Bridges J.P.; McCormack F.X.; Surfactant lipid peroxidation damages surfactant protein A and inhibits interactions with phospholipid vesicles. J Lipid Res 2004,45(6),1061-1068","journal-title":"J Lipid Res"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"S0077","DOI":"10.5702\/massspectrometry.S0077","volume":"7","author":"Enami S.","year":"2018","unstructured":"Enami S.; Colussi A.J.; OH-Radical Oxidation of Lung Surfactant Protein B on Aqueous Surfaces. Mass Spectrom (Tokyo) 2018,7(2),S0077","journal-title":"Mass Spectrom (Tokyo)"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/ja908477w","volume":"132","author":"Kim H.I.","year":"2010","unstructured":"Kim H.I.; Kim H.; Shin Y.S.; Beegle L.W.; Jang S.S.; Neidholdt E.L.; Goddard W.A.; Heath J.R.; Kanik I.; Beauchamp J.L.; Interfacial reactions of ozone with surfactant protein B in a model lung surfactant system. J Am Chem Soc 2010,132(7),2254-2263","journal-title":"J Am Chem Soc"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000349928","volume":"103","author":"Sweet D.G.","year":"2013","unstructured":"Sweet D.G.; Carnielli V.; Greisen G.; Hallman M.; Ozek E.; Plavka R.; Saugstad O.D.; Simeoni U.; Speer C.P.; Vento M.; Halliday H.L.; European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology 2013,103(4),353-368","journal-title":"Neonatology"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1164\/ajrccm.163.1.2005029","volume":"163","author":"Cavicchioli P.","year":"2001","unstructured":"Cavicchioli P.; Zimmermann L.J.; Cogo P.E.; Badon T.; Giordano G.; Torresin M.; Zacchello F.; Carnielli V.P.; Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med 2001,163(1),55-60","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=262","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001456.pub2","volume":"11","author":"Bahadue F.L.","year":"2012","unstructured":"Bahadue F.L.; Soll R.; Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2012,11","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1038\/sj.jp.7211320","volume":"25","author":"Suresh G.K.","year":"2005","unstructured":"Suresh G.K.; Soll R.F.; Overview of surfactant replacement trials. J Perinatol 2005,25(S2)(Suppl. 2),S40-S44","journal-title":"J Perinatol"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000499361","volume":"115","author":"Sweet D.G.","year":"2019","unstructured":"Sweet D.G.; Carnielli V.; Greisen G.; Hallman M.; Ozek E.; Te Pas A.; Plavka R.; Roehr C.C.; Saugstad O.D.; Simeoni U.; Speer C.P.; Vento M.; Visser G.H.A.; Halliday H.L.; European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology 2019,115(4),432-450","journal-title":"Neonatology"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/jp.2009.31","volume":"29","author":"Ramanathan R.","year":"2009","unstructured":"Ramanathan R.; Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials. J Perinatol 2009,29(S2)(Suppl. 2),S38-S43","journal-title":"J Perinatol"},{"key":"ref=266","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000144.pub3","volume":"8","author":"Ardell S.","year":"2015","unstructured":"Ardell S.; Pfister R.H.; Soll R.; Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2015,8","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=267","first-page":"1","volume":"88","author":"Phibbs R.H.","year":"1991","unstructured":"Phibbs R.H.; Ballard R.A.; Clements J.A.; Heilbron D.C.; Phibbs C.S.; Schlueter M.A.; Sniderman S.H.; Tooley W.H.; Wakeley A.; Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Pediatrics 1991,88(1),1-9","journal-title":"Pediatrics"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pupt.2015.08.005","volume":"34","author":"Zhang L.","year":"2015","unstructured":"Zhang L.; Cao H.Y.; Zhao S.; Yuan L.J.; Han D.; Jiang H.; Wu S.; Wu H.M.; Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials. Pulm Pharmacol Ther 2015,34,46-54","journal-title":"Pulm Pharmacol Ther"},{"key":"ref=269","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006069.pub3","author":"Pfister R.H.","year":"2007","unstructured":"Pfister R.H.; Soll R.F.; Wiswell T.; Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2007(4)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1542\/peds.2004-2231","volume":"115","author":"Sinha S.K.","year":"2005","unstructured":"Sinha S.K.; Lacaze-Masmonteil T.; Valls i Soler A.; Wiswell T.E.; Gadzinowski J.; Hajdu J.; Bernstein G.; Sanchez-Luna M.; Segal R.; Schaber C.J.A.; Massaro J.; d\u2019Agostino R.; A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005,115(4),1030-1038","journal-title":"Pediatrics"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1542\/peds.2004-2183","volume":"115","author":"Moya F.R.","year":"2005","unstructured":"Moya F.R.; Gadzinowski J.; Bancalari E.; Salinas V.; Kopelman B.; Bancalari A.; Kornacka M.K.; Merritt T.A.; Segal R.; Schaber C.J.A.; Tsai H.; Massaro J.; d\u2019Agostino R.; A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 2005,115(4),1018-1029","journal-title":"Pediatrics"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/08035250600615168","volume":"95","author":"Mazela J.","year":"2006","unstructured":"Mazela J.; Merritt T.A.; Gadzinowski J.; Sinha S.; Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases. Acta Paediatr 2006,95(9),1036-1048","journal-title":"Acta Paediatr"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/0140-6736(93)93062-6","volume":"341","author":"Moya F.R.","year":"1993","unstructured":"Moya F.R.; Hoffman D.R.; Zhao B.; Johnston J.M.; Platelet-activating factor in surfactant preparations. Lancet 1993,341(8849),858-860","journal-title":"Lancet"},{"key":"ref=274","year":"2020","unstructured":"Curosurf (Poractant Alfa) Intratracheal Suspension [Prescribing Information] 2020","journal-title":"Curosurf (Poractant Alfa) Intratracheal Suspension [Prescribing Information]"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/ajrccm.162.4.9908104","volume":"162","year":"2000","unstructured":"BERNHARD, W.; MOTTAGHIAN, J.; GEBERT, A.; RAU, G. A.; von der HARDT, H.; POETS, C. F. Commercial versus Native Surfactants. Am J Respir Crit Care Med 2000,162(4),1524-1533","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=276","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204050","volume":"13","author":"Lugones Y.","year":"2018","unstructured":"Lugones Y.; Blanco O.; L&#xF3;pez-Rodr&#xED;guez E.; Echaide M.; Cruz A.; P&#xE9;rez-Gil J.; Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin. PLoS One 2018,13(9)","journal-title":"PLoS One"},{"key":"ref=277","author":"V&#xE1;zquez O.M.","unstructured":"V&#xE1;zquez O.M.; L&#xF3;pez M.L.; Dieppa F.D.; L&#xF3;pez M.A.P.; Abad A.A.; Rivero G.J.; Tapia D.M.; Estudio de La Eficacia Del Surfacen En El Distress Respiratorio Del Reci&#xE9;n Nacido Rev Cubana Pediatr, 1999, 71(2) [Article In Cuban]","journal-title":"Estudio de La Eficacia Del Surfacen En El Distress Respiratorio Del Reci&#xE9;n Nacido Rev Cubana Pediatr, 1999, 71(2) [Article In Cuban]"},{"key":"ref=278","author":"Manzanares D.","unstructured":"Manzanares D.; D&#xED;az E.; Alfonso W.; Escobar A.; Colom&#xE9; H.; Mu&#xF1;oz M.C.; Noa M.; Rabell S.; Hidalgo A.; Surfactante Pulmonar Porcino Rep&#xFA;blica de Cuba (Article In Cuban), 1995, 35-42","journal-title":"Surfactante Pulmonar Porcino Rep&#xFA;blica de Cuba (Article In Cuban), 1995, 35-42"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.resp.2016.07.009","volume":"233","year":"2016","unstructured":"Cimato; Hoyos Obando; Facorro; Mart&#xED;nez Sarrasague. Analysis of the Structure and Surfactant Activity of Novel Formulations Containing Exogenous Pulmonary Surfactant and Glucocorticoids. Respir Physiol Neurobiol 2016,233,33-40","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=280","unstructured":"Nialtec. Prosurf. Available from: http:\/\/Www.Nialtec.Com"},{"key":"ref=281","author":"Hager A.","year":"2001","unstructured":"Hager A.; De Paoli T.; Method for Extracting and Purifying Pulmonary Surfactant. U.S. Patent 6172203B1, 2001"},{"key":"ref=282","unstructured":"Survanta (Beractant) [Prescribing Information]AbbVie Inc: North Chicago, IL, 2019","journal-title":"Survanta (Beractant) [Prescribing Information]AbbVie Inc: North Chicago, IL, 2019"},{"key":"ref=283","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.93.06070971","volume":"6","author":"Seeger W.","year":"1993","unstructured":"Seeger W.; Grube C.; G&#xFC;nther A.; Schmidt R.; Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993,6(7),971-977","journal-title":"Eur Respir J"},{"key":"ref=284","author":"Gregoriadis G.","unstructured":"Gregoriadis G.;"},{"key":"ref=285","doi-asserted-by":"publisher","unstructured":"Inpharma Weekly, 2003, 1395(1), 22.","DOI":"10.2165\/00128413-200313950-00047"},{"key":"ref=286","author":"Bautin A.E.","unstructured":"Bautin A.E.; Osovskikh V.V.; Khubulava G.G.; Granov D.A.; Kozlov I.A.; Erokhin V.V.; Multicenter Clinical Trials of Surfactant-BL for the Treatment of Adult Respiratory Distress Syndrome Clinical Research of Drugs in Russia, 2002, (2), 18-23 [Article In Russian]","journal-title":"Multicenter Clinical Trials of Surfactant-BL for the Treatment of Adult Respiratory Distress Syndrome Clinical Research of Drugs in Russia, 2002, (2), 18-23 [Article In Russian]"},{"key":"ref=287","year":"2018","unstructured":"Infasurf (Calfactant)[Prescribing Information] 2018","journal-title":"Infasurf (Calfactant)[Prescribing Information]"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1542\/peds.100.1.31","volume":"100","author":"Bloom B.T.","year":"1997","unstructured":"Bloom B.T.; Kattwinkel J.; Hall R.T.; Delmore P.M.; Egan E.A.; Trout J.R.; Malloy M.H.; Brown D.R.; Holzman I.R.; Coghill C.H.; Carlo W.A.; Pramanik A.K.; McCaffree M.A.; Toubas P.L.; Laudert S.; Gratny L.L.; Weatherstone K.B.; Seguin J.H.; Willett L.D.; Gutcher G.R.; Mueller D.H.; Topper W.H.; Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997,100(1),31-38","journal-title":"Pediatrics"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"L567","DOI":"10.1152\/ajplung.1995.269.5.L567","volume":"269","author":"Kahn M.C.","year":"1995","unstructured":"Kahn M.C.; Anderson G.J.; Anyan W.R.; Hall S.B.; Phosphatidylcholine molecular species of calf lung surfactant. Am J Physiol 1995,269(5 Pt 1),L567-L573","journal-title":"Am J Physiol"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1055\/s-2004-44899","volume":"216","author":"Yalaz M.","year":"2004","unstructured":"Yalaz M.; Arslanoglu S.; Akisu M.; Atik T.; Ergun O.; Kultursay N.; A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome. Klin Padiatr 2004,216(4),230-235","journal-title":"Klin Padiatr"},{"key":"ref=291","unstructured":"Wauer Respiratory Distress SyndromeWauer, RR, Ed; Surfactant Therapy: Basic Principles, Diagnosis, Therapy; Thieme Medical Publication: Stuttgart, Germany, 1998, pp 2-19","journal-title":"Wauer Respiratory Distress SyndromeWauer, RR, Ed; Surfactant Therapy: Basic Principles, Diagnosis, Therapy; Thieme Medical Publication: Stuttgart, Germany, 1998, pp 2-19"},{"key":"ref=292","year":"2012","unstructured":"BLES Biochemicals Inc Canadian BLES (Bovine Lipid Extract Surfactant) Product Monograph;2012","journal-title":"BLES Biochemicals Inc"},{"key":"ref=293","unstructured":"Government of Canada. Report on New Patented Drugs - BLES. Available from: http:\/\/Www.Pmprb-Cepmb.Gc.ca\/View.Asp?Ccid=592"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/BF02535391","volume":"18","author":"Yu S.","year":"1983","unstructured":"Yu S.; Harding P.G.; Smith N.; Possmayer F.; Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 1983,18(8),522-529","journal-title":"Lipids"},{"key":"ref=295","unstructured":"Package Insert Calf Pulmonary Surfactant for Injection, Calsurf."},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41390-020-0750-8","volume":"88","author":"Hentschel R.","year":"2020","unstructured":"Hentschel R.; Bohlin K.; van Kaam A.; Fuchs H.; Danhaive O.; Surfactant replacement therapy: from biological basis to current clinical practice. Pediatr Res 2020,88(2),176-183","journal-title":"Pediatr Res"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/jp.2011.125","volume":"33","author":"Ramanathan R.","year":"2013","unstructured":"Ramanathan R.; Bhatia J.J.; Sekar K.; Ernst F.R.; Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: A retrospective study. J Perinatol 2013,33(2),119-125","journal-title":"J Perinatol"},{"key":"ref=298","author":"S&#xE1;nchez-Mendiola M.","unstructured":"S&#xE1;nchez-Mendiola M.; Mart&#xED;nez-Natera O.C.; Herrera-Maldonado N.; Ortega-Arroyo J.; Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: A controlled study Gac Med Mex, 2005, 141(4), 267-271 [Article In Cuban]","journal-title":"Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: A controlled study Gac Med Mex, 2005, 141(4), 267-271 [Article In Cuban]"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1016\/j.bbamem.2012.06.023","volume":"1818","author":"Blanco O.","year":"2012","unstructured":"Blanco O.; Cruz A.; Ospina O.L.; L&#xF3;pez-Rodriguez E.; V&#xE1;zquez L.; P&#xE9;rez-Gil J.; Interfacial behavior and structural properties of a clinical lung surfactant from porcine source. Biochim Biophys Acta 2012,1818(11),2756-2766","journal-title":"Biochim Biophys Acta"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1542\/peds.2011-0725","volume":"129","author":"Wang H.","year":"2012","unstructured":"Wang H.; Gao X.; Liu C.; Yan C.; Lin X.; Yang C.; Lin Z.; Zhu W.; Yang Z.; Yu F.; Qiu Y.; Liu X.; Zhou X.; Chen C.; Sun B.; Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. Pediatrics 2012,129(3),e731-e740","journal-title":"Pediatrics"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1055\/s-0039-1678530","volume":"36","author":"Rong Z.","year":"2019","unstructured":"Rong Z.; Chang L.; Cheng H.; Wang H.; Zhu X.; Peng F.; Fan Q.; Lu W.; Pan R.; Xiong L.; Jiao R.; Sun J.; Xia S.; Xie J.; A Multicentered Randomized Study on Early versus Rescue Calsurf Administration for the Treatment of Respiratory Distress Syndrome in Preterm Infants. Am J Perinatol 2019,36(14),1492-1497","journal-title":"Am J Perinatol"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pedneo.2015.03.007","volume":"57","author":"Kong X.","year":"2016","unstructured":"Kong X.; Cui Q.; Hu Y.; Huang W.; Ju R.; Li W.; Wang R.; Xia S.; Yu J.; Zhu T.; Feng Z.; Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks\u2019 Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study. Pediatr Neonatol 2016,57(1),19-26","journal-title":"Pediatr Neonatol"},{"key":"ref=303","year":"2018","unstructured":"Infasurf (Calfactant) [Prescribing Information] 2018","journal-title":"Infasurf (Calfactant) [Prescribing Information]"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1203\/00006450-198506000-00014","volume":"19","author":"Notter R.H.","year":"1985","unstructured":"Notter R.H.; Egan E.A.; Kwong M.S.; Holm B.A.; Shapiro D.L.; Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age. Pediatr Res 1985,19(6),569-577","journal-title":"Pediatr Res"},{"key":"ref=305","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-021576","volume":"146","author":"Glaser K.","year":"2020","unstructured":"Glaser K.; Wright C.J.; Aerosolized Calfactant in Infants With RDS: Surfactant Replacement 2.0? Pediatrics 2020,146(5)","journal-title":"Pediatrics"},{"key":"ref=306","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3967","volume":"146","author":"Cummings J.J.","year":"2020","unstructured":"Cummings J.J.; Gerday E.; Minton S.; Katheria A.; Albert G.; Flores-Torres J.; Famuyide M.; Lampland A.; Guthrie S.; Kuehn D.; Weitkamp J.H.; Fort P.; Abu Jawdeh E.G.; Ryan R.M.; Martin G.C.; Swanson J.R.; Mulrooney N.; Eyal F.; Gerstmann D.; Kumar P.; Wilding G.E.; Egan E.A.; Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial. Pediatrics 2020,146(5)","journal-title":"Pediatrics"},{"key":"ref=307","volume":"146","author":"Bianco F.R.E.","year":"2020","unstructured":"Bianco F.R.E.; Surfactant Aerosolization: Technical Details That Matter. Pediatrics 2020,146(5)","journal-title":"Pediatrics"},{"key":"ref=308","unstructured":"Onybiotech Latest News: Aerosolized Surfactant, the Trial Results Are in Available from: Https:\/\/Www.Onybiotech. Com\/Aerosolized-Surfactant-the-Trial-Results-Are-in\/","journal-title":"Onybiotech Latest News: Aerosolized Surfactant, the Trial Results Are in Available from:"},{"key":"ref=309","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-319804","author":"Roberts C. T.","unstructured":"Roberts C. T.; Manley B. J.; O\u2019Shea J. E.; Stark M.; Andersen C.; Davis P. G.; Buckmaster A.; Supraglottic Airway Devices for Administration of Surfactant to Newborn Infants with Respiratory Distress Syndrome: A Narrative ReviewArch Dis Child Fetal Neonatal Ed prepub,319804","journal-title":"Supraglottic Airway Devices for Administration of Surfactant to Newborn Infants with Respiratory Distress Syndrome: A Narrative ReviewArch Dis Child Fetal Neonatal Ed prepub,319804"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1089\/jamp.2017.ab01.abstracts","volume":"30","author":"DiBlasi R.","year":"2017","unstructured":"DiBlasi R.; Micheletti K.J.; Chan M.; Zimmermann J.; Telfer C.; Fink J.B.; Abstracts: International Society for Aerosols in Medicine e.V. 21st ISAM Congress Santa Fe, NM June 3-7, 2017. J Aerosol Med Pulm Drug Deliv 2017,30(3),A1-A38","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=311","doi-asserted-by":"publisher","unstructured":"Jardine, J.; Liley, H. AN OPEN\u2010LABEL STUDY OF SAFETY AND TOLERABILITY OF AEROFACTTM (AEROSOLIZED ALVEOFACT&#xAE;) IN PRETERM INFANTS ON NCPAP AT RISK FOR WORSENING RESPIRATORY DISTRESS SYNDROME. J. Paediatr. Child Health, 2019, 55(Suppl. 1), 27.","DOI":"10.1111\/jpc.14409_66"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000337354","volume":"101","author":"Pillow J.J.","year":"2012","unstructured":"Pillow J.J.; Minocchieri S.; Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012,101(4),337-344","journal-title":"Neonatology"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ppul.24603","volume":"55","author":"Nord A.","year":"2020","unstructured":"Nord A.; Linner R.; Salomone F.; Bianco F.; Ricci F.; Murgia X.; Schlun M.; Cunha-Goncalves D.; Perez-de-Sa V.; Lung deposition of nebulized surfactant in newborn piglets: Nasal CPAP vs Nasal IPPV. Pediatr Pulmonol 2020,55(2),514-520","journal-title":"Pediatr Pulmonol"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12931-019-1096-9","volume":"20","author":"Bianco F.","year":"2019","unstructured":"Bianco F.; Ricci F.; Catozzi C.; Murgia X.; Schlun M.; Bucholski A.; Hetzer U.; Bonelli S.; Lombardini M.; Pasini E.; Nutini M.; Pertile M.; Minocchieri S.; Simonato M.; Rosa B.; Pieraccini G.; Moneti G.; Lorenzini L.; Catinella S.; Villetti G.; Civelli M.; Pioselli B.; Cogo P.; Carnielli V.; Dani C.; Salomone F.; From bench to bedside: In vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy. Respir Res 2019,20(1),134","journal-title":"Respir Res"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ppul.22838","volume":"49","author":"Minocchieri S.","year":"2014","unstructured":"Minocchieri S.; Knoch S.; Schoel W.M.; Ochs M.; Nelle M.; Nebulizing poractant alfa versus conventional instillation: Ultrastructural appearance and preservation of surface activity. Pediatr Pulmonol 2014,49(4),348-356","journal-title":"Pediatr Pulmonol"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1203\/PDR.0b013e318175dcfa","volume":"64","author":"Minocchieri S.","year":"2008","unstructured":"Minocchieri S.; Burren J.M.; Bachmann M.A.; Stern G.; Wildhaber J.; Buob S.; Schindel R.; Kraemer R.; Frey U.P.; Nelle M.; Development of the premature infant nose throat-model (PrINT-Model): An upper airway replica of a premature neonate for the study of aerosol delivery. Pediatr Res 2008,64(2),141-146","journal-title":"Pediatr Res"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1097\/PCC.0000000000002313","volume":"21","author":"Rey-Santano C.","year":"2020","unstructured":"Rey-Santano C.; Mielgo V.; Gomez-Solaetxe M.A.; Ricci F.; Bianco F.; Salomone F.; Loureiro B.; Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets. Pediatr Crit Care Med 2020,21(7),e456-e466","journal-title":"Pediatr Crit Care Med"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1097\/CCM.0000000000004318","volume":"48","author":"Rey-Santano C.","year":"2020","unstructured":"Rey-Santano C.; Mielgo V.E.; Gomez-Solaetxe M.A.; Bianco F.; Salomone F.; Loureiro B.; Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets. Crit Care Med 2020,48(6),e523-e531","journal-title":"Crit Care Med"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"F313","DOI":"10.1136\/archdischild-2018-315051","volume":"104","author":"Minocchieri S.","year":"2019","unstructured":"Minocchieri S.; Berry C.A.; Pillow J.J.; Nebulised surfactant to reduce severity of respiratory distress: A blinded, parallel, randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2019,104(3),F313-F319","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=320","first-page":"113","volume":"107","author":"Narayanan S.","year":"1998","unstructured":"Narayanan S.; Paul V.K.; Singh M.; Pande J.N.; Rao D.N.; Vijayaraghvan M.; Deorari A.K.; Preparation","journal-title":"Indian J Med Res"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41372-019-0472-0","volume":"39","author":"Jain K.","year":"2019","unstructured":"Jain K.; Nangia S.; Ballambattu V.B.; Sundaram V.; Sankar M.J.; Ramji S.; Vishnubhatla S.; Thukral A.; Gupta Y.K.; Plakkal N.; Sundaram M.; Jajoo M.; Kumar P.; Jayaraman K.; Jain A.; Saili A.; Murugesan A.; Chawla D.; Murki S.; Nanavati R.; Rao S.; Vaidya U.; Mehta A.; Arora K.; Mondkar J.; Arya S.; Bahl M.; Utture A.; Manerkar S.; Bhat S.R.; Parikh T.; Kumar M.; Bajpai A.; Sivanandan S.; Dhawan P.K.; Vishwakarma G.; Bangera S.; Kumar S.; Gopalakrishnan S.; Jindal A.; Natarajan C.K.; Saini A.; Karunanidhi S.; Malik M.; Narang P.; Kaur G.; Yadav C.P.; Deorari A.; Paul V.K.; Agarwal R.; Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: A multi-site randomized non-inferiority trial. J Perinatol 2019,39(Suppl. 1),3-12","journal-title":"J Perinatol"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1194\/jlr.M085431","volume":"59","author":"Madsen J.","year":"2018","unstructured":"Madsen J.; Panchal M.H.; Mackay R.A.; Echaide M.; Koster G.; Aquino G.; Pelizzi N.; Perez-Gil J.; Salomone F.; Clark H.W.; Postle A.D.; Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice. J Lipid Res 2018,59(10),1880-1892","journal-title":"J Lipid Res"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14787210.2017.1259067","volume":"15","author":"Glaser K.","year":"2017","unstructured":"Glaser K.; Fehrholz M.; Henrich B.; Claus H.; Papsdorf M.; Speer C.P.; Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes. Expert Rev Anti Infect Ther 2017,15(2),181-189","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/pr.2016.231","volume":"81","author":"Ricci F.","year":"2017","unstructured":"Ricci F.; Murgia X.; Razzetti R.; Pelizzi N.; Salomone F.; In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633. Pediatr Res 2017,81(2),369-375","journal-title":"Pediatr Res"},{"key":"ref=325","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039392","volume":"7","author":"Sato A.","year":"2012","unstructured":"Sato A.; Ikegami, M. SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=326","doi-asserted-by":"publisher","unstructured":"Ramanathan, R.; Biniwale, M.; Sekar, K.; Hanna, N.; Golombek, S.; Bhatia, J.; Naylor, M.; Fabbri, L.; Varoli, G.; Santoro, D.; Del Buono, D.; Piccinno, A.; Dammann, C.E. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized Controlled Clinical Trial. J. Pediatr., 2020, 225, 90-96.e1. Ramanathan; Biniwale; Sekar; Hanna; Golombek; Bhatia; Naylor; Fabbri; Varoli; Santoro; et al. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome:","DOI":"10.1016\/j.jpeds.2020.06.024"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"F497","DOI":"10.1136\/archdischild-2017-312722","volume":"102","author":"Sweet D.G.","year":"2017","unstructured":"Sweet D.G.; Turner M.A.; Stra\u0148&#xE1;k Z.; Plavka R.; Clarke P.; Stenson B.J.; Singer D.; Goelz R.; Fabbri L.; Varoli G.; Piccinno A.; Santoro D.; Speer C.P.; A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 2017,102(6),F497-F503","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=328","author":"Guardia C.","year":"2019","unstructured":"Guardia C.; Simmons P.; Segal R.; Finer N.; Moya F.; Mazela J.; Gregory T.; Simonson S.; Abstracts 2019 Annual Meeting of the Pediatric Academic Societies (PAS) 2019","journal-title":"Abstracts 2019 Annual Meeting of the Pediatric Academic Societies (PAS)"},{"key":"ref=329","author":"Mazela J.","year":"2018","unstructured":"Mazela J.; Finer N.; Segal R.; Simmons P.; Weinstein L.; Simonson S.; Abstracts: 7th Congress of the European Academy of Paediatric Societies Held Jointly with the 2018 Annual Meeting of the European Academy of Paediatrics( EAP) 2018 Annual Meeting of the European Society for Paediatric Research (ESPR) and European Society of Paediatric and Neonatal Intensive Care (ESPNIC), 2018","journal-title":"Abstracts: 7th Congress of the European Academy of Paediatric Societies Held Jointly with the 2018 Annual Meeting of the European Academy of Paediatrics( EAP) 2018 Annual Meeting of the European Society for Paediatric Research (ESPR) and European Society of Paediatric and Neonatal Intensive Care (ESPNIC),"},{"key":"ref=330","unstructured":"Airway Therapeutics: Pipeline Available from: https:\/\/www.airwaytherapeutics.com\/pipeline\/"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1164\/rccm.200509-1485OC","volume":"173","author":"Ikegami M.","year":"2006","unstructured":"Ikegami M.; Carter K.; Bishop K.; Yadav A.; Masterjohn E.; Brondyk W.; Scheule R.K.; Whitsett J.A.; Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006,173(12),1342-1347","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"19214","DOI":"10.1074\/jbc.M010191200","volume":"276","author":"Zhang L.","year":"2001","unstructured":"Zhang L.; Ikegami M.; Crouch E.C.; Korfhagen T.R.; Whitsett J.A.; Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J Biol Chem 2001,276(22),19214-19219","journal-title":"J Biol Chem"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"L468","DOI":"10.1152\/ajplung.2000.279.3.L468","volume":"279","author":"Ikegami M.","year":"2000","unstructured":"Ikegami M.; Whitsett J.A.; Jobe A.; Ross G.; Fisher J.; Korfhagen T.; Surfactant metabolism in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 2000,279(3),L468-L476","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"28438","DOI":"10.1074\/jbc.273.43.28438","volume":"273","author":"Korfhagen T.R.","year":"1998","unstructured":"Korfhagen T.R.; Sheftelyevich V.; Burhans M.S.; Bruno M.D.; Ross G.F.; Wert S.E.; Stahlman M.T.; Jobe A.H.; Ikegami M.; Whitsett J.A.; Fisher J.H.; Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998,273(43),28438-28443","journal-title":"J Biol Chem"},{"key":"ref=335","unstructured":"Airway Therapeutics: Press Release Available from: https:\/\/Www.Airwaytherapeutics.Com\/Airway-Therapeu-tics-Closes-15-5-Million-Series-c-Financing-to-Advance-Preclinical-and-Clinical-Research-and-Development-Programs-to-Prevent-and-Treat-Serious-Respiratory-Diseases\/"},{"key":"ref=336","unstructured":"Acorda Therapeutics. ARCUS&#xAE;: Innovative Technology Platform for Inhaled Medicines. Available from: http:\/\/www.acorda.com\/products\/arcus-technology"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"6","DOI":"10.12688\/gatesopenres.12899.2","volume":"3","author":"Walther F.J.","year":"2019","unstructured":"Walther F.J.; Gupta M.; Lipp M.M.; Chan H.; Krzewick J.; Gordon L.M.; Waring A.J.; Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support. Gates Open Res 2019,3,6","journal-title":"Gates Open Res"},{"key":"ref=338","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23277","volume":"110","author":"Brown N.J.","year":"2019","unstructured":"Brown N.J.; Lin J.S.; Barron A.E.; Helical side chain chemistry of a peptoid-based SP-C analogue: Balancing structural rigidity and biomimicry. Biopolymers 2019,110(6)","journal-title":"Biopolymers"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1038\/s41598-018-25009-3","volume":"8","author":"Czyzewski A.M.","year":"2018","unstructured":"Czyzewski A.M.; McCaig L.M.; Dohm M.T.; Broering L.A.; Yao L-J.; Brown N.J.; Didwania M.K.; Lin J.S.; Lewis J.F.; Veldhuizen R.; Barron A.E.; Effective in vivo treatment of acute lung injury with helical, amphipathic peptoid mimics of pulmonary surfactant proteins. Sci Rep 2018,8(1),6795","journal-title":"Sci Rep"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.bpj.2011.04.055","volume":"101","author":"Brown N.J.","year":"2011","unstructured":"Brown N.J.; Dohm M.T.; Bernardino de la Serna J.; Barron A.E.; Biomimetic N-terminal alkylation of peptoid analogues of surfactant protein C. Biophys J 2011,101(5),1076-1085","journal-title":"Biophys J"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.bbamem.2010.04.012","volume":"1798","author":"Dohm M.T.","year":"2010","unstructured":"Dohm M.T.; Brown N.J.; Seurynck-Servoss S.L.; Bernardino de la Serna J.; Barron A.E.; Mimicking SP-C palmitoylation on a peptoid-based SP-B analogue markedly improves surface activity. Biochim Biophys Acta 2010,1798(9),1663-1678","journal-title":"Biochim Biophys Acta"},{"key":"ref=342","unstructured":"Trimunocor: Our Solution Available from: http:\/\/www. trimunocor.com\/solution.html","journal-title":"Trimunocor: Our Solution Available from:"},{"key":"ref=343","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000297770","volume":"97","author":"Clark H.W.","year":"2010","unstructured":"Clark H.W.; Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease? Neonatology 2010,97(4),380-387","journal-title":"Neonatology"},{"key":"ref=344","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ar.20830","volume":"292","author":"Knudsen L.","year":"2009","unstructured":"Knudsen L.; Wucherpfennig K.; Mackay R.M.; Townsend P.; M&#xFC;hlfeld C.; Richter J.; Hawgood S.; Reid K.; Clark H.; Ochs M.; A recombinant fragment of human surfactant protein D lacking the short collagen-like stalk fails to correct morphological alterations in lungs of SP-D deficient mice. Anat Rec (Hoboken) 2009,292(2),183-189","journal-title":"Anat Rec (Hoboken)"},{"key":"ref=345","unstructured":"Innovus Synsurf: Synthetic Lung Surfactant 2009 Available from: Https:\/\/Www.Innovus.Co.Za\/Technologies\/ Medicine-and-Health-1\/Therapeutics-and-PharmaceuticsSynsurf-Synthetic-Lung-Surfactant.Html","journal-title":"Innovus Synsurf: Synthetic Lung Surfactant 2009 Available from:"},{"key":"ref=346","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.2147\/DDDT.S147035","volume":"12","author":"van Rensburg L.","year":"2018","unstructured":"van Rensburg L.; van Zyl J.M.; Smith J.; Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf&#xAE; within a pressurized metered dose inhaler: A Calu-3 model. Drug Des Devel Ther 2018,12,1107-1118","journal-title":"Drug Des Devel Ther"},{"key":"ref=347","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/DDDT.S47270","volume":"2013","author":"van Zyl J.M.","year":"2013","unstructured":"van Zyl J.M.; Smith, J Surfactant Treatment before First Breath for Respiratory Distress Syndrome in Preterm Lambs: Comparison of a Peptide-Containing Synthetic Lung Surfactant with Porcine-Derived Surfactant. Drug Des Devel Ther 2013,2013,905-916","journal-title":"Drug Des Devel Ther"},{"key":"ref=348","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3349\/ymj.2017.58.4.823","volume":"58","author":"Choi Y-S.","year":"2017","unstructured":"Choi Y-S.; Chung S-H.; Bae C-W.; A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In vitro and Animal Experiments. Yonsei Med J 2017,58(4),823-828","journal-title":"Yonsei Med J"},{"key":"ref=349","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3349\/ymj.2016.57.1.203","volume":"57","author":"Bae C-W.","year":"2016","unstructured":"Bae C-W.; Chung S-H.; Choi Y-S.; Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In vitro Studies of Surface Physical Properties. Yonsei Med J 2016,57(1),203-208","journal-title":"Yonsei Med J"},{"key":"ref=350","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1038\/jp.2009.32","volume":"29","author":"Carnielli V.P.","year":"2009","unstructured":"Carnielli V.P.; Zimmermann L.J.I.; Hamvas A.; Cogo P.E.; Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes. J Perinatol 2009,29(S2)(Suppl. 2),S29-S37","journal-title":"J Perinatol"},{"key":"ref=351","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.1542\/neo.7-2-e95","volume":"7","author":"Jobe A.H.","year":"2006","unstructured":"Jobe A.H.; Pharmacology Review: Why Surfactant Works for Respiratory Distress Syndrome. Neoreviews 2006,7(2),E95-E106","journal-title":"Neoreviews"},{"key":"ref=352","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.prrv.2009.12.006","volume":"11","author":"Smith L.J.","year":"2010","unstructured":"Smith L.J.; McKay K.O.; van Asperen P.P.; Selvadurai H.; Fitzgerald D.A.; Normal development of the lung and premature birth. Paediatr Respir Rev 2010,11(3),135-142","journal-title":"Paediatr Respir Rev"},{"key":"ref=353","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamapediatrics.2015.2401","volume":"169","author":"Jensen E.A.","year":"2015","unstructured":"Jensen E.A.; DeMauro S.B.; Kornhauser M.; Aghai Z.H.; Greenspan J.S.; Dysart K.C.; Effects of Multiple Ventilation Courses and Duration of Mechanical Ventilation on Respiratory Outcomes in Extremely Low-Birth-Weight Infants. JAMA Pediatr 2015,169(11),1011-1017","journal-title":"JAMA Pediatr"},{"key":"ref=354","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000458466","volume":"111","author":"Niemarkt H.J.","year":"2017","unstructured":"Niemarkt H.J.; H&#xFC;tten M.C.; Kramer B.W.; Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications. Neonatology 2017,111(4),408-414","journal-title":"Neonatology"},{"key":"ref=355","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.e24","volume":"103","author":"Verder H.","year":"1999","unstructured":"Verder H.; Albertsen P.; Ebbesen F.; Greisen G.; Robertson B.; Bertelsen A.; Agertoft L.; Djernes B.; Nathan E.; Reinholdt J.; Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks\u2019 gestation. Pediatrics 1999,103(2)","journal-title":"Pediatrics"},{"key":"ref=356","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1203\/00006450-199709000-00016","volume":"42","author":"Bj&#xF6;rklund L.J.","year":"1997","unstructured":"Bj&#xF6;rklund L.J.; Ingimarsson J.; Curstedt T.; John J.; Robertson B.; Werner O.; Vilstrup C.T.; Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997,42(3),348-355","journal-title":"Pediatr Res"},{"key":"ref=357","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1460-9592.2006.02126.x","volume":"17","year":"2006","unstructured":"A.; PILLEKAMP, F.; H&#xDC;NSELER, C.; VIERZIG, A.; ROTH, B. Early Administration of Surfactant in Spontaneous Breathing with NCPAP: Feasibility and Outcome in Extremely Premature Infants (Postmenstrual Age \u226427\u2003Weeks). Paediatr Anaesth 2006,17(4),364-369","journal-title":"Paediatr Anaesth"},{"key":"ref=358","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.2016.10708","volume":"316","author":"Isayama T.","year":"2016","unstructured":"Isayama T.; Iwami H.; McDonald S.; Beyene J.; Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis. JAMA 2016,316(6),611-624","journal-title":"JAMA"},{"key":"ref=359","doi-asserted-by":"publisher","first-page":"F17","DOI":"10.1136\/archdischild-2015-310299","volume":"102","author":"Aldana-Aguirre J.C.","year":"2017","unstructured":"Aldana-Aguirre J.C.; Pinto M.; Featherstone R.M.; Kumar M.; Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2017,102(1),F17-F23","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=360","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-319763","author":"Bellos I.","unstructured":"Bellos I.; Fitrou G.; Panza R.; Pandita A.; Arch Dis Child Fetal Neonatal Ed,2021, fetalneonatal-2020-319763","journal-title":"Arch Dis Child Fetal Neonatal Ed,2021, fetalneonatal-2020-319763"},{"key":"ref=361","doi-asserted-by":"publisher","DOI":"10.1177\/2333794X17696683","volume":"4","author":"Lau C.S.M.","year":"2017","unstructured":"Lau C.S.M.; Chamberlain R.S.; Sun S.; Less Invasive Surfactant Administration Reduces the Need for Mechanical Ventilation in Preterm Infants: A Meta-Analysis. Glob Pediatr Health 2017,4","journal-title":"Glob Pediatr Health"},{"key":"ref=362","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamapediatrics.2015.0504","volume":"169","author":"Kribs A.","year":"2015","unstructured":"Kribs A.; Roll C.; G&#xF6;pel W.; Wieg C.; Groneck P.; Laux R.; Teig N.; Hoehn T.; B&#xF6;hm W.; Welzing L.; Vochem M.; Hoppenz M.; B&#xFC;hrer C.; Mehler K.; St&#xFC;tzer H.; Franklin J.; St&#xF6;hr A.; Herting E.; Roth B.; Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr 2015,169(8),723-730","journal-title":"JAMA Pediatr"},{"key":"ref=363","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00431-020-03682-9","volume":"179","author":"Gupta B.K.","year":"2020","unstructured":"Gupta B.K.; Saha A.K.; Mukherjee S.; Saha B.; Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial. Eur J Pediatr 2020,179(8),1287-1293","journal-title":"Eur J Pediatr"},{"key":"ref=364","doi-asserted-by":"publisher","first-page":"F655","DOI":"10.1136\/archdischild-2018-316557","volume":"104","author":"Herting E.","year":"2019","unstructured":"Herting E.; Ha rtel, C.; Go pel, W. Less Invasive Surfactant Administration (LISA). Chances and Limitations Arch Dis Child Fetal Neonatal Ed 2019,104(6),F655-F659","journal-title":"Chances and Limitations Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=365","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2015.11.035","volume":"170","author":"van der Burg P.S.","year":"2016","unstructured":"van der Burg P.S.; de Jongh F.H.; Miedema M.; Frerichs I.; van Kaam A.H.; Effect of Minimally Invasive Surfactant Therapy on Lung Volume and Ventilation in Preterm Infants. J Pediatr 2016,170,67-72","journal-title":"J Pediatr"},{"key":"ref=366","doi-asserted-by":"publisher","first-page":"F323","DOI":"10.1136\/archdischild-2015-308204","volume":"101","author":"Oncel M.Y.","year":"2016","unstructured":"Oncel M.Y.; Arayici S.; Uras N.; Alyamac-Dizdar E.; Sari F.N.; Karahan S.; Canpolat F.E.; Oguz S.S.; Dilmen U.; Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2016,101(4),F323-F328","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=367","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/pr.2014.66","volume":"76","author":"Niemarkt H.J.","year":"2014","unstructured":"Niemarkt H.J.; Kuypers E.; Jellema R.; Ophelders D.; H&#xFC;tten M.; Nikiforou M.; Kribs A.; Kramer B.W.; Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution, and lung compliance in spontaneously breathing preterm lambs. Pediatr Res 2014,76(2),166-170","journal-title":"Pediatr Res"},{"key":"ref=368","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-01324-2","author":"Ricci F.","year":"2021","unstructured":"Ricci F.; Bresesti I.; LaVerde P.A.M.; Salomone F.; Casiraghi C.; Mersanne A.; Storti M.; Catozzi C.; Tigli L.; Zecchi R.; Franceschi P.; Murgia X.; Simonato M.; Cogo P.; Carnielli V.; Lista G.; Surfactant lung delivery with LISA and InSurE in adult rabbits with respiratory distress. Pediatr Res 2021","journal-title":"Pediatr Res"},{"key":"ref=369","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ppul.24277","volume":"54","author":"Rey-Santano C.","year":"2019","unstructured":"Rey-Santano C.; Mielgo V.E.; Gomez-Solaetxe M.A.; Salomone F.; Gastiasoro E.; Loureiro B.; Cerebral oxygenation associated with INSURE versus LISA procedures in surfactant-deficient newborn piglet RDS model. Pediatr Pulmonol 2019,54(5),644-654","journal-title":"Pediatr Pulmonol"},{"key":"ref=370","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0037-1598647","volume":"48","author":"Bertini G.","year":"2017","unstructured":"Bertini G.; Coviello C.; Gozzini E.; Bianconi T.; Bresci C.; Leonardi V.; Dani C.; Change of Cerebral Oxygenation during Surfactant Treatment in Preterm Infants: &#x201C;LISA&#x201D; versus &#x201C;InSurE&#x201D; Procedures. Neuropediatrics 2017,48(2),98-103","journal-title":"Neuropediatrics"},{"key":"ref=371","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/apa.14060","volume":"107","author":"Lamberska T.","year":"2018","unstructured":"Lamberska T.; Settelmayerova E.; Smisek J.; Luksova M.; Maloskova G.; Plavka R.; Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation. Acta Paediatr 2018,107(1),73-78","journal-title":"Acta Paediatr"},{"key":"ref=372","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41372-018-0281-x","volume":"39","author":"Calevo M.G.","year":"2019","unstructured":"Calevo M.G.; Veronese N.; Cavallin F.; Paola C.; Micaglio M.; Trevisanuto D.; Supraglottic airway devices for surfactant treatment: systematic review and meta-analysis. J Perinatol 2019,39(2),173-183","journal-title":"J Perinatol"},{"key":"ref=373","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.294.6578.991","volume":"294","year":"1987","unstructured":"Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Br Med J (Clin Res Ed) 1987,294(6578),991-996","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=374","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/sj.jp.7211103","volume":"24","author":"Kattwinkel J.","year":"2004","unstructured":"Kattwinkel J.; Robinson M.; Bloom B.T.; Delmore P.; Ferguson J.E.; Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004,24(6),360-365","journal-title":"J Perinatol"},{"key":"ref=375","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035994","volume":"10","author":"Murphy M.C.","year":"2020","unstructured":"Murphy M.C.; Galligan M.; Molloy B.; Hussain R.; Doran P.; O\u2019Donnell C.; Study protocol for the POPART study-Prophylactic Oropharyngeal surfactant for Preterm infants: A Randomised Trial. BMJ Open 2020,10(7)","journal-title":"BMJ Open"},{"key":"ref=376","doi-asserted-by":"publisher","first-page":"F485","DOI":"10.1136\/adc.2003.038430","volume":"89","author":"Trevisanuto D.","year":"2004","unstructured":"Trevisanuto D.; Micaglio M.; Ferrarese P.; Zanardo V.; The laryngeal mask airway: potential applications in neonates. Arch Dis Child Fetal Neonatal Ed 2004,89(6),F485-F489","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=377","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000481979","volume":"113","author":"Bansal S.C.","year":"2018","unstructured":"Bansal S.C.; Caoci S.; Dempsey E.; Trevisanuto D.; Roehr C.C.; The Laryngeal Mask Airway and Its Use in Neonatal Resuscitation: A Critical Review of Where We Are in 2017\/2018. Neonatology 2018,113(2),152-161","journal-title":"Neonatology"},{"key":"ref=378","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinane.2016.10.004","volume":"36","author":"van Esch B.F.","year":"2017","unstructured":"van Esch B.F.; Stegeman I.; Smit A.L.; Comparison of laryngeal mask airway vs tracheal intubation: A systematic review on airway complications. J Clin Anesth 2017,36,142-150","journal-title":"J Clin Anesth"},{"key":"ref=379","first-page":"346","volume":"3","author":"Arroe M.","year":"1998","unstructured":"Arroe M.; Pedersen-Bjergaard L.; Albertsen P.; Bode S.; Greisen G.; Inhalation of Aerosolized Surfactant Exosurf to Neonates Treated with Nasal Continuous Positive Airway Pressure. Prenat Neonatal Med 1998,3,346-352","journal-title":"Prenat Neonatal Med"},{"key":"ref=380","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O","volume":"24","author":"Jorch G.","year":"1997","unstructured":"Jorch G.; Hartl H.; Roth B.; Kribs A.; Gortner L.; Schaible T.; Hennecke K.H.; Surfactant Aerosol Treatment of Respiratory Distress Syndrome in Spontaneously Breathing Premature Infants. Pediatr Pulmonol 1997,24(3),222-224","journal-title":"Pediatr Pulmonol"},{"key":"ref=381","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1651-2227.2000.tb00084.x","volume":"89","author":"Berggren E.","year":"2000","unstructured":"Berggren E.; Liljedahl M.; Winbladh B.; Andreasson B.; Curstedt T.; Robertson B.; Schollin J.; Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000,89(4),460-464","journal-title":"Acta Paediatr"},{"key":"ref=382","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00431-010-1292-6","volume":"170","author":"Mazela J.","year":"2011","unstructured":"Mazela J.; Polin R.A.; Aerosol delivery to ventilated newborn infants: historical challenges and new directions. Eur J Pediatr 2011,170(4),433-444","journal-title":"Eur J Pediatr"},{"key":"ref=383","doi-asserted-by":"publisher","first-page":"F275","DOI":"10.1136\/adc.2007.121285","volume":"93","author":"K&#xF6;hler E.","year":"2008","unstructured":"K&#xF6;hler E.; Jilg G.; Avenarius S.; Jorch G.; Lung deposition after inhalation with various nebulisers in preterm infants. Arch Dis Child Fetal Neonatal Ed 2008,93(4),F275-F279","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=384","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1203\/01.PDR.0000156244.84422.55","volume":"58","author":"Dubus J.C.","year":"2005","unstructured":"Dubus J.C.; Vecellio L.; De Monte M.; Fink J.B.; Grimbert D.; Montharu J.; Valat C.; Behan N.; Diot P.; Aerosol deposition in neonatal ventilation. Pediatr Res 2005,58(1),10-14","journal-title":"Pediatr Res"},{"key":"ref=385","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/jamp.2009.0758","volume":"23","author":"Finer N.N.","year":"2010","unstructured":"Finer N.N.; Merritt T.A.; Bernstein G.; Job L.; Mazela J.; Segal R.; An open label, pilot study of Aerosurf&#xAE; combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv 2010,23(5),303-309","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=386","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030257","volume":"12","author":"Bianco F.","year":"2020","unstructured":"Bianco F.; Pasini E.; Nutini M.; Murgia X.; Stoeckl C.; Schlun M.; Hetzer U.; Bonelli S.; Lombardini M.; Milesi I.; Pertile M.; Minocchieri S.; Salomone F.; Bucholski A.; In vitro Performance of an Investigational Vibrating-Membrane Nebulizer with Surfactant under Simulated, Non-Invasive Neonatal Ventilation Conditions: Influence of Continuous Positive Airway Pressure Interface and Nebulizer Positioning on the Lung Dose. Pharmaceutics 2020,12(3)","journal-title":"Pharmaceutics"},{"key":"ref=387","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/jamp.2018.1505","volume":"33","author":"Gregory T.J.","year":"2020","unstructured":"Gregory T.J.; Irshad H.; Chand R.; Kuehl P.J.; Deposition of Aerosolized Lucinactant in Nonhuman Primates. J Aerosol Med Pulm Drug Deliv 2020,33(1),21-33","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=388","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721392","author":"Nord A.","year":"2020","unstructured":"Nord A.; Bianco F.; Salomone F.; Ricci F.; Schlun M.; Linner R.; Cunha-Goncalves D.; Nebulization of High-Dose Poractant Alfa in Newborn Piglets on Nasal Continuous Positive Airway Pressure Yields Therapeutic Lung Doses of Phospholipids. Am J Perinatol 2020","journal-title":"Am J Perinatol"},{"key":"ref=389","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12931-020-01585-9","volume":"22","author":"Bianco F.","year":"2021","unstructured":"Bianco F.; Salomone F.; Milesi I.; Murgia X.; Bonelli S.; Pasini E.; Dellac&#xE0; R.; Ventura M.L.; Pillow J.; Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned. Respir Res 2021,22(1),71","journal-title":"Respir Res"},{"key":"ref=390","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/jcph.1675","volume":"60","author":"Foligno S.","year":"2020","unstructured":"Foligno S.; Loi B.; Pezza L.; Piastra M.; Autilio C.; De Luca D.; Extrapulmonary Surfactant Therapy: Review of Available Data and Research\/Development Issues. J Clin Pharmacol 2020,60(12),1561-1572","journal-title":"J Clin Pharmacol"},{"key":"ref=391","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"Ranieri V.M.","year":"2012","unstructured":"Ranieri V.M.; Rubenfeld G.D.; Thompson B.T.; Ferguson N.D.; Caldwell E.; Fan E.; Camporota L.; Slutsky A.S.; Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012,307(23),2526-2533","journal-title":"JAMA"},{"key":"ref=392","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/PCC.0000000000000432","volume":"16","author":"Khemani R.G.","year":"2015","unstructured":"Khemani R.G.; Smith L.S.; Zimmerman J.J.; Erickson S.; Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015,16(5)(Suppl. 1),S23-S40","journal-title":"Pediatr Crit Care Med"},{"key":"ref=393","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"Matthay M.A.","year":"2019","unstructured":"Matthay M.A.; Zemans R.L.; Zimmerman G.A.; Arabi Y.M.; Beitler J.R.; Mercat A.; Herridge M.; Randolph A.G.; Calfee C.S.; Acute respiratory distress syndrome. Nat Rev Dis Primers 2019,5(1),18","journal-title":"Nat Rev Dis Primers"},{"key":"ref=394","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1165\/rcmb.F305","volume":"33","author":"Matthay M.A.","year":"2005","unstructured":"Matthay M.A.; Zimmerman G.A.; Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005,33(4),319-327","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=395","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1465-9921-8-55","volume":"8","author":"Schmidt R.","year":"2007","unstructured":"Schmidt R.; Markart P.; Ruppert C.; Wygrecka M.; Kuchenbuch T.; Walmrath D.; Seeger W.; Guenther A.; Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res 2007,8,55","journal-title":"Respir Res"},{"key":"ref=396","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ccc.2011.04.005","volume":"27","author":"Raghavendran K.","year":"2011","unstructured":"Raghavendran K.; Willson D.; Notter R.H.; Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin 2011,27(3),525-559","journal-title":"Crit Care Clin"},{"key":"ref=397","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1378\/chest.14-1139","volume":"148","author":"Willson D.F.","year":"2015","unstructured":"Willson D.F.; Truwit J.D.; Conaway M.R.; Traul C.S.; Egan E.E.; The Adult Calfactant in Acute Respiratory Distress Syndrome Trial. Chest 2015,148(2),356-364","journal-title":"Chest"},{"key":"ref=398","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/rccm.201009-1424OC","volume":"183","author":"Spragg R.G.","year":"2011","unstructured":"Spragg R.G.; Taut F.J.H.; Lewis J.F.; Schenk P.; Ruppert C.; Dean N.; Krell K.; Karabinis A.; G&#xFC;nther A.; Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med 2011,183(8),1055-1061","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=399","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-018-0761-y","volume":"19","author":"Meng S-S.","year":"2019","unstructured":"Meng S-S.; Chang W.; Lu Z-H.; Xie J-F.; Qiu H-B.; Yang Y.; Guo F-M.; Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. BMC Pulm Med 2019,19(1),9","journal-title":"BMC Pulm Med"},{"key":"ref=400","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fped.2020.00210","volume":"8","author":"Deliloglu B.","year":"2020","unstructured":"Deliloglu B.; Tuzun F.; Cengiz M.M.; Ozkan H.; Duman N.; Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS. Front Pediatr 2020,8,210","journal-title":"Front Pediatr"},{"key":"ref=401","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","volume":"334","author":"Anzueto A.","year":"1996","unstructured":"Anzueto A.; Baughman R.P.; Guntupalli K.K.; Weg J.G.; Wiedemann H.P.; Ravent&#xF3;s A.A.; Lemaire F.; Long W.; Zaccardelli D.S.; Pattishall E.N.; Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996,334(22),1417-1421","journal-title":"N Engl J Med"},{"key":"ref=402","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1164\/ajrccm.155.4.9105072","volume":"155","author":"Gregory T.J.","year":"1997","unstructured":"Gregory T.J.; Steinberg K.P.; Spragg R.; Gadek J.E.; Hyers T.M.; Longmore W.J.; Moxley M.A.; Cai G.Z.; Hite R.D.; Smith R.M.; Hudson L.D.; Crim C.; Newton P.; Mitchell B.R.; Gold A.J.; Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997,155(4),1309-1315","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=403","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1073\/pnas.1504025112","volume":"112","author":"Filoche M.","year":"2015","unstructured":"Filoche M.; Tai C-F.; Grotberg J.B.; Three-dimensional model of surfactant replacement therapy. Proc Natl Acad Sci USA 2015,112(30),9287-9292","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=404","first-page":"56","volume":"83","author":"Busani S.","year":"2012","unstructured":"Busani S.; Girardis M.; Exogenous Surfactant, a Role in the Adult Acute Respiratory Distress Syndrome? Acta Biomed 2012,83,56-59","journal-title":"Acta Biomed"},{"key":"ref=405","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1164\/rccm.201401-0168CP","volume":"190","author":"Kneyber M.C.J.","year":"2014","unstructured":"Kneyber M.C.J.; Zhang H.; Slutsky A.S.; Ventilator-induced lung injury. Similarity and differences between children and adults. Am J Respir Crit Care Med 2014,190(3),258-265","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=406","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S2213-2600(18)30429-6","volume":"7","author":"De Luca D.","year":"2019","unstructured":"De Luca D.; Personalising care of acute respiratory distress syndrome according to patients\u2019 age. Lancet Respir Med 2019,7(2),100-101","journal-title":"Lancet Respir Med"},{"key":"ref=407","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1164\/rccm.202004-1471LE","volume":"202","author":"Koumbourlis A.C.","year":"2020","unstructured":"Koumbourlis A.C.; Motoyama E.K.; Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment? Am J Respir Crit Care Med 2020,202(4),624-626","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=408","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. Available from: Https:\/\/Covid19.Who.Int\/"},{"key":"ref=409","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5847876","volume":"2020","author":"Li Y.","year":"2020","unstructured":"Li Y.; Wu Q.; Sun X.; Shen J.; Chen H.; Organoids as a Powerful Model for Respiratory Diseases. Stem Cells Int 2020,2020","journal-title":"Stem Cells Int"},{"key":"ref=410","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.mehy.2020.110020","year":"2020","unstructured":"Takano. Pulmonary Surfactant Itself Must Be a Strong Defender against SARS-CoV-2. Med Hypotheses 2020,144","journal-title":"Med Hypotheses"},{"key":"ref=411","doi-asserted-by":"publisher","unstructured":"Ghati, A.; Dam, P.; Tasdemir, D.; Kati, A.; Sellami, H.; Sezgin, G.C.; Ildiz, N.; Franco, O.L.; Mandal, A.K.; Ocsoy, I. Exogenous Pulmonary Surfactant: A Review Focused on Adjunctive Therapy for SARS CoV-2 Including SP-A and SP-D as Added Clinical Marker. Curr. Opin. Colloid Interface Sci., 2020, 101413","DOI":"10.1016\/j.cocis.2020.101413"},{"key":"ref=412","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1865809","author":"Veldhuizen R.A.W.","year":"2020","unstructured":"Veldhuizen R.A.W.; Zuo Y.Y.; Petersen N.O.; Lewis J.F.; Possmayer F.; The COVID-19 Pandemic: A Target for Surfactant Therapy? Expert Rev Respir Med 2020","journal-title":"Expert Rev Respir Med"},{"key":"ref=413","unstructured":"Windtree Therapeutics. Press Releases: Windtree Announces FDA Acceptance of IND Application for a Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19. Available from: http:\/\/windtreetx.investorroom.com\/2020-09-29-Windtree-Announces-FDA-Acceptance-of-IND-Application-for-a-Phase-2-Clinical-Trial-Studying-KL4-Surfactant-in-Acute-Lung-Injury-in-Adults-with-COVID-19"},{"key":"ref=414","unstructured":"Onybiotech: Our Company. Available from: https:\/\/www. onybiotech.com\/our-company\/"},{"key":"ref=415","unstructured":"iol.co.za. business-report, companies: Stellenbosch University and SA company joins global fight against Covid-19. Available from: https:\/\/www.iol.co.za\/business-report\/companies\/stellenbosch-university-and-sa-company-joinsglobal-fight-against-covid-19-45655950"},{"key":"ref=416","unstructured":"Airway Therapeutics. Press release. Available from: https:\/\/www.airwaytherapeutics.com\/airway-therapeutics-announces-filing-with-nih-to-evaluate-at-100-as-a-therapy-for-novel-coronavirus\/"},{"key":"ref=417","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000369373","volume":"107","author":"Lindenskov P.H.","year":"2015","unstructured":"Lindenskov P.H.; Castellheim A.; Saugstad O.D.; Mollnes T.E.; Meconium aspiration syndrome: possible pathophysiological mechanisms and future potential therapies. Neonatology 2015,107(3),225-230","journal-title":"Neonatology"},{"key":"ref=418","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/321545","volume":"2012","author":"Fischer C.","year":"2012","unstructured":"Fischer C.; Rybakowski C.; Ferdynus C.; Sagot P.; Gouyon J.B.; A Population-Based Study of Meconium Aspiration Syndrome in Neonates Born between 37 and 43 Weeks of Gestation. Int J Pediatr 2012,2012","journal-title":"Int J Pediatr"},{"key":"ref=419","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1203\/01.pdr.0000214685.31232.6a","volume":"59","author":"Sippola T.","year":"2006","unstructured":"Sippola T.; Aho H.; Peuravuori H.; Lukkarinen H.; Gunn J.; K&#xE4;&#xE4;p&#xE4; P.; Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr Res 2006,59(5),641-645","journal-title":"Pediatr Res"},{"key":"ref=420","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00134-011-2243-z","volume":"37","author":"De Luca D.","year":"2011","unstructured":"De Luca D.; Minucci A.; Tripodi D.; Piastra M.; Pietrini D.; Zuppi C.; Conti G.; Carnielli V.P.; Capoluongo E.; Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates. Intensive Care Med 2011,37(7),1158-1165","journal-title":"Intensive Care Med"},{"key":"ref=421","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002054.pub3","author":"El Shahed A.I.","year":"2014","unstructured":"El Shahed A.I.; Dargaville P.A.; Ohlsson A.; Soll R.; Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst Rev 2014(12)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=422","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/jp.2016.32","volume":"36","author":"Natarajan C.K.","year":"2016","unstructured":"Natarajan C.K.; Sankar M.J.; Jain K.; Agarwal R.; Paul V.K.; Surfactant therapy and antibiotics in neonates with meconium aspiration syndrome: A systematic review and meta-analysis. J Perinatol 2016,36(S1)(Suppl. 1),S49-S54","journal-title":"J Perinatol"},{"key":"ref=423","first-page":"1345","volume":"80","author":"Boet A.","year":"2014","unstructured":"Boet A.; Brat R.; Aguilera S.S.; Tissieres P.; De Luca D.; Surfactant from neonatal to pediatric ICU: bench and bedside evidence. Minerva Anestesiol 2014,80(12),1345-1356","journal-title":"Minerva Anestesiol"},{"key":"ref=424","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/01902148.2017.1420272","volume":"44","author":"Mikolka P.","year":"2018","unstructured":"Mikolka P.; Kopincova J.; Kosutova P.; Kolomaznik M.; Calkovska A.; Mokra D.; Anti-IL-8 antibody potentiates the effect of exogenous surfactant in respiratory failure caused by meconium aspiration. Exp Lung Res 2018,44(1),40-50","journal-title":"Exp Lung Res"},{"key":"ref=425","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejcts.2008.09.039","volume":"35","author":"Amital A.","year":"2009","unstructured":"Amital A.; Shitrit D.; Raviv Y.; Saute M.; Bakal I.; Medalion B.; Kramer M.R.; Surfactant as salvage therapy in life threatening primary graft dysfunction in lung transplantation. Eur J Cardiothorac Surg 2009,35(2),299-303","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref=426","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.healun.2016.11.010","volume":"36","year":"2017","unstructured":"J Heart Lung Transplant Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration- Induced Donor Lung Injury.2017,36(5),577-585","journal-title":"J Heart Lung Transplant"},{"key":"ref=427","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1183\/09031936.00020810","volume":"37","author":"S&#xE1;enz A.","year":"2011","unstructured":"S&#xE1;enz A.; lvarez, L.; Santos, M.; L pez-S nchez, A.; Castillo-Olivares, J. L.; Varela, A.; Segal, R.; Casals, C. Beneficial Effects of Synthetic KL4 Surfactant in Experimental Lung Transplantation. Eur Respir J 2011,37(4),925-932","journal-title":"Eur Respir J"},{"key":"ref=428","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1097\/TP.0b013e31818a8418","volume":"86","author":"Amital A.","year":"2008","unstructured":"Amital A.; Shitrit D.; Raviv Y.; Saute M.; Medalion B.; Bakal L.; Kramer M.R.; The use of surfactant in lung transplantation. Transplantation 2008,86(11),1554-1559","journal-title":"Transplantation"},{"key":"ref=429","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.jtcvs.2006.12.057","volume":"133","author":"Str&#xFC;ber M.","year":"2007","unstructured":"Str&#xFC;ber M.; Fischer S.; Niedermeyer J.; Warnecke G.; Gohrbandt B.; G&#xF6;rler A.; Simon A.R.; Haverich A.; Hohlfeld J.M.; Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial. J Thorac Cardiovasc Surg 2007,133(6),1620-1625","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=430","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s001340050967","volume":"25","author":"Str&#xFC;ber M.","year":"1999","unstructured":"Str&#xFC;ber M.; Hirt S.W.; Cremer J.; Harringer W.; Haverich A.; Surfactant replacement in reperfusion injury after clinical lung transplantation. Intensive Care Med 1999,25(8),862-864","journal-title":"Intensive Care Med"},{"key":"ref=431","author":"Wittwer T.","unstructured":"Wittwer T.; Madershahian N.; Rahmanian V.; Choi Y.; Neef K.; Ochs M.; Wahlers T.; In: Abstract at 25th EACTS; , 2011; p S92","journal-title":"In: Abstract at 25th EACTS; , 2011; p S92"},{"key":"ref=432","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/j.healun.2012.01.654","volume":"31","year":"2012","unstructured":"Bertani; DeMonte; Vitulo; Soresi; Callari; Tuzzolino; Di Paola; Arcadipane; Gridelli. 640 The Administration of Exogenous Surfactant during Cold Preservation Can Improve Pulmonary Function after Lung Transplantation in a Swine Model of Prolonged Ischemia. J Heart Lung Transplant 2012,31(4),S221","journal-title":"J Heart Lung Transplant"},{"key":"ref=433","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1164\/ajrccm.154.1.8680706","volume":"154","author":"Novick R.J.","year":"1996","unstructured":"Novick R.J.; MacDonald J.; Veldhuizen R.A.; Wan F.; Duplan J.; Denning L.; Possmayer F.; Gilpin A.A.; Yao L.J.; Bjarneson D.; Lewis J.F.; Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996,154(1),98-104","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=434","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.athoracsur.2012.10.027","volume":"95","author":"Inci I.","year":"2013","unstructured":"Inci I.; Hillinger S.; Arni S.; Jungraithmayr W.; Inci D.; Vogt P.; Leskosek B.; Hansen G.; Weder W.; Surfactant improves graft function after gastric acid-induced lung damage in lung transplantation. Ann Thorac Surg 2013,95(3),1013-1019","journal-title":"Ann Thorac Surg"},{"key":"ref=435","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1016\/j.healun.2015.01.245","volume":"34","year":"2015","unstructured":"J Heart Lung Transplant Lung Lavage and Surfactant Administration for the Ex Vivo Pre-Transplant Treatment of Donor Lungs Injured Due to Gastric Acid Aspiration.2015,34(4),S92","journal-title":"J Heart Lung Transplant"},{"key":"ref=436","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.healun.2013.01.922","volume":"32","author":"Khalife T.","year":"2013","unstructured":"Khalife T.; Sage E.; Dorfmuller P.; Eddahibi S.; Fadel E.; Lung Injuries Induced by Gastric Acid Aspiration Are Attenuated by Exogenous Surfactant during Ex Vivo Reconditioning in Pigs. J Heart Lung Transplant 2013,32(4),S47","journal-title":"J Heart Lung Transplant"},{"key":"ref=437","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/(SICI)1099-0496(199812)26:6<438:AID-PPUL10>3.0.CO;2-V","volume":"26","author":"Newth C.J.L.","year":"1998","unstructured":"Newth C.J.L.; Hammer J.; Pulmonary function in ventilated infants with bronchiolitis. Pediatr Pulmonol 1998,26(6),438-441","journal-title":"Pediatr Pulmonol"},{"key":"ref=438","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/(SICI)1099-0496(199703)23:3<176:AID-PPUL2>3.0.CO;2-M","volume":"23","author":"Hammer J.","year":"1997","unstructured":"Hammer J.; Numa A.; Newth C.J.L.; Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr Pulmonol 1997,23(3),176-183","journal-title":"Pediatr Pulmonol"},{"key":"ref=439","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S2213-2600(18)30344-8","volume":"7","author":"Khemani R.G.","year":"2019","unstructured":"Khemani R.G.; Smith L.; Lopez-Fernandez Y.M.; Kwok J.; Morzov R.; Klein M.J.; Yehya N.; Willson D.; Kneyber M.C.J.; Lillie J.; Fernandez A.; Newth C.J.L.; Jouvet P.; Thomas N.J.; Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): An international, observational study. Lancet Respir Med 2019,7(2),115-128","journal-title":"Lancet Respir Med"},{"key":"ref=440","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/adc.75.2.133","volume":"75","author":"Dargaville P.A.","year":"1996","unstructured":"Dargaville P.A.; South M.; McDougall P.N.; Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 1996,75(2),133-136","journal-title":"Arch Dis Child"},{"key":"ref=441","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","volume":"162","author":"Tibby S.M.","year":"2000","unstructured":"Tibby S.M.; Hatherill M.; Wright S.M.; Wilson P.; Postle A.D.; Murdoch I.A.; Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000,162(4 Pt 1),1251-1256","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=442","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/milmed\/usx204","volume":"183","author":"Al-Saiedy M.","year":"2018","unstructured":"Al-Saiedy M.; Gunasekara L.; Green F.; Pratt R.; Chiu A.; Yang A.; Dennis J.; Pieron C.; Bjornson C.; Winston B.; Amrein M.; Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins. Mil Med 2018,183(Suppl. 1),207-215","journal-title":"Mil Med"},{"key":"ref=443","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ppul.21395","volume":"46","author":"Barreira E.R.","year":"2011","unstructured":"Barreira E.R.; Precioso A.R.; Bousso A.; Pulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implications. Pediatr Pulmonol 2011,46(5),415-420","journal-title":"Pediatr Pulmonol"},{"key":"ref=444","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/PCC.0b013e3181dbe95e","volume":"12","author":"De Luca D.","year":"2011","unstructured":"De Luca D.; Minucci A.; Cogo P.; Capoluongo E.D.; Conti G.; Pietrini D.; Carnielli V.P.; Piastra M.; Secretory phospholipase A pathway during pediatric acute respiratory distress syndrome: A preliminary study. Pediatr Crit Care Med 2011,12(1),e20-e24","journal-title":"Pediatr Crit Care Med"},{"key":"ref=445","doi-asserted-by":"publisher","first-page":"L559","DOI":"10.1152\/ajplung.90507.2008","volume":"297","author":"Bruce S.R.","year":"2009","unstructured":"Bruce S.R.; Atkins C.L.; Colasurdo G.N.; Alcorn J.L.; Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. Am J Physiol Lung Cell Mol Physiol 2009,297(4),L559-L567","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=446","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2019.06.011","volume":"142","author":"Torres-Cuevas I.","year":"2019","unstructured":"Torres-Cuevas I.; Corral-Debrinski M.; Gressens P.; Brain oxidative damage in murine models of neonatal hypoxia\/ischemia and reoxygenation. Free Radic Biol Med 2019,142,3-15","journal-title":"Free Radic Biol Med"},{"key":"ref=447","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1749-6632.2000.tb05536.x","volume":"923","year":"2006","unstructured":"A. L. Rationale for the Development of Recombinant Human CC10 as a Therapeutic for Inflammatory and Fibrotic Disease. Ann N Y Acad Sci 2006,923(1),280-299","journal-title":"Ann N Y Acad Sci"},{"key":"ref=448","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.semperi.2006.09.002","volume":"30","author":"Hallman M.","year":"2006","unstructured":"Hallman M.; Haataja R.; Surfactant protein polymorphisms and neonatal lung disease. Semin Perinatol 2006,30(6),350-361","journal-title":"Semin Perinatol"},{"key":"ref=449","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1203\/00006450-199912000-00023","volume":"46","author":"Wang S.Z.","year":"1999","unstructured":"Wang S.Z.; Doyle I.R.; Nicholas T.E.; Forsyth K.D.; Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis. Pediatr Res 1999,46(6),731-734","journal-title":"Pediatr Res"},{"key":"ref=450","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ppul.21270","volume":"46","author":"Kawasaki Y.","year":"2011","unstructured":"Kawasaki Y.; Endo K.; Suyama K.; Sato M.; Ito M.; Hashimoto K.; Hosoya M.; Serum SP-D levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Pediatr Pulmonol 2011,46(1),18-22","journal-title":"Pediatr Pulmonol"},{"key":"ref=451","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.chest.2020.03.041","volume":"158","author":"Dahmer M.K.","year":"2020","unstructured":"Dahmer M.K.; Flori H.; Sapru A.; Kohne J.; Weeks H.M.; Curley M.A.Q.; Matthay M.A.; Quasney M.W.; Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure. Chest 2020,158(3),1027-1035","journal-title":"Chest"},{"key":"ref=452","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009194.pub3","author":"Jat K.R.","year":"2015","unstructured":"Jat K.R.; Chawla D.; Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev 2015(8)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=453","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-038780","volume":"10","author":"Biban P.","year":"2020","unstructured":"Biban P.; Conti G.; Wolfler A.M.; Carlassara S.; Gitto E.; Rulli I.; Moscatelli A.; Micalizzi C.; Savron F.; Sagredini R.; Genoni G.; Binotti M.; Caramelli F.; Fae M.; Pettenazzo A.; Stritoni V.; D\u2019Amato L.; Zito Marinosci G.; Calderini E.; Scalia Catenacci S.; Berardi A.; Torcetta F.; Bonanomi E.; Bonacina D.; Ivani G.; Santuz P.; Efficacy and safety of exogenous surfactant therapy in patients under 12 months of age invasively ventilated for severe bronchiolitis (SURFABRON): protocol for a multicentre, randomised, double-blind, controlled, non-profit trial. BMJ Open 2020,10(10)","journal-title":"BMJ Open"},{"key":"ref=454","unstructured":"ISRCTN Registry. The Bronchiolitis Endotracheal Surfactant Study (BESS). Available from: http:\/\/Www. Isrctn. Com\/ISRCTN11746266"},{"key":"ref=455","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000049371","volume":"69","author":"Baughman R.P.","year":"2002","unstructured":"Baughman R.P.; Henderson R.F.; Whitsett J.; Gunther K.L.; Keeton D.A.; Waide J.J.; Zaccardelli D.S.; Pattishall E.N.; Rashkin M.C.; Surfactant replacement for ventilator-associated pneumonia: A preliminary report. Respiration 2002,69(1),57-62","journal-title":"Respiration"},{"key":"ref=456","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1183\/09031936.97.10091989","volume":"10","author":"Griese M.","year":"1997","unstructured":"Griese M.; Bufler P.; Teller J.; Reinhardt D.; Nebulization of a bovine surfactant in cystic fibrosis: A pilot study. Eur Respir J 1997,10(9),1989-1994","journal-title":"Eur Respir J"},{"key":"ref=457","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/00325481.2015.1028872","volume":"127","author":"Atkinson H.","year":"2015","unstructured":"Atkinson H.; Wallis S.; Coatesworth A.P.; Acute otitis media. Postgrad Med 2015,127(4),386-390","journal-title":"Postgrad Med"},{"key":"ref=458","first-page":"350","volume":"100","author":"Gaddey H.L.","year":"2019","unstructured":"Gaddey H.L.; Wright M.T.; Nelson T.N.; Otitis Media: Rapid Evidence Review. Am Fam Physician 2019,100(6),350-356","journal-title":"Am Fam Physician"},{"key":"ref=459","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00005537-200403000-00017","volume":"114","author":"Chandrasekhar S.S.","year":"2004","unstructured":"Chandrasekhar S.S.; Mautone A.J.; Otitis media: treatment with intranasal aerosolized surfactant. Laryngoscope 2004,114(3),472-485","journal-title":"Laryngoscope"},{"key":"ref=460","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0194-5998(94)70799-5","volume":"110","author":"Fornadley J.A.","year":"1994","unstructured":"Fornadley J.A.; Burns J.K.; Burns J.K.; The effect of surfactant on eustachian tube function in a gerbil model of otitis media with effusion. Otolaryngol Head Neck Surg 1994,110(1),110-114","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=461","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3342\/ceo.2010.3.1.13","volume":"3","author":"Jang C.H.","year":"2010","unstructured":"Jang C.H.; Cho Y.B.; Oh S.E.; Choi J.U.; Park H.; Choi C.H.; Effect of nebulized bovine surfactant for experimental otitis media with effusion. Clin Exp Otorhinolaryngol 2010,3(1),13-17","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"ref=462","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijporl.2009.10.020","volume":"74","author":"Jang C.H.","year":"2010","unstructured":"Jang C.H.; Park H.; Choi C.H.; Cho Y.B.; Park I.Y.; Efficacy of transnasal nebulized surfactant on experimental otitis media with effusion in guinea pig. Int J Pediatr Otorhinolaryngol 2010,74(1),71-74","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref=463","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ijporl.2007.08.017","volume":"71","author":"Ma Z.","year":"2007","unstructured":"Ma Z.; Dai C.; Yang S.; Li M.; Qi L.; Protective effect of pulmonary surfactant on cilia of Eustachian tube in otitis media with effusion. Int J Pediatr Otorhinolaryngol 2007,71(12),1889-1895","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref=464","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/lary.24166","volume":"123","author":"Zhu Z.H.","year":"2013","unstructured":"Zhu Z.H.; Shan Y.J.; Han Y.; Zhu L.W.; Ma Z.X.; Pathological study of otitis media with effusion after treatment with intranasal pulmonary surfactant. Laryngoscope 2013,123(12),3148-3155","journal-title":"Laryngoscope"},{"key":"ref=465","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ijporl.2008.03.019","volume":"72","author":"Johnson D.","year":"2008","unstructured":"Johnson D.; Chandrasekhar S.S.; Mautone A.J.; Intranasal phenylephrine-surfactant treatment is not beneficial in otitis media with effusion. Int J Pediatr Otorhinolaryngol 2008,72(7),1085-1089","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref=466","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2018.10.012","volume":"291","author":"Guagliardo R.","year":"2018","unstructured":"Guagliardo R.; P&#xE9;rez-Gil J.; De Smedt S.; Raemdonck K.; Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins. J Control Release 2018,291,116-126","journal-title":"J Control Release"},{"key":"ref=467","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","volume":"11","author":"Ghadiri M.","year":"2019","unstructured":"Ghadiri M.; Young P.M.; Traini D.; Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics 2019,11(3),113","journal-title":"Pharmaceutics"},{"key":"ref=468","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bcp.2019.03.036","volume":"164","author":"Baer B.","year":"2019","unstructured":"Baer B.; Souza L.M.P.; Pimentel A.S.; Veldhuizen R.A.W.; New insights into exogenous surfactant as a carrier of pulmonary therapeutics. Biochem Pharmacol 2019,164,64-73","journal-title":"Biochem Pharmacol"},{"key":"ref=469","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.02.014","author":"Hidalgo A.","unstructured":"Hidalgo A.; Cruz A.; P&#xE9;rez-Gil J.; Barrier or carrier? Pulmonary surfactant and drug deliveryEur J Pharm Biopharm, 2015, 95(Pt A), 117-127","journal-title":"Barrier or carrier? Pulmonary surfactant and drug deliveryEur J Pharm Biopharm, 2015, 95(Pt A), 117-127"},{"key":"ref=470","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1021\/acs.langmuir.7b01177","volume":"33","author":"Hidalgo A.","year":"2017","unstructured":"Hidalgo A.; Salomone F.; Fresno N.; Orellana G.; Cruz A.; Perez-Gil J.; Efficient Interfacially Driven Vehiculization of Corticosteroids by Pulmonary Surfactant. Langmuir 2017,33(32),7929-7939","journal-title":"Langmuir"},{"key":"ref=471","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bbamem.2017.04.019","volume":"1859","author":"Hidalgo A.","year":"2017","unstructured":"Hidalgo A.; Cruz A.; P&#xE9;rez-Gil J.; Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications. Biochim Biophys Acta Biomembr 2017,1859(9 Pt B),1740-1748","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=472","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejpb.2019.09.020","volume":"144","author":"Garcia-Mouton C.","year":"2019","unstructured":"Garcia-Mouton C.; Hidalgo A.; Cruz A.; P&#xE9;rez-Gil J.; The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles. Eur J Pharm Biopharm 2019,144,230-243","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=473","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1039\/C6RA28422A","volume":"7","year":"2017","unstructured":"Estrada-L pez, E. D.; Murce, E.; Franca, M. P. P.; Pimentel, A. S. Prednisolone Adsorption on Lung Surfactant Models: Insights on the Formation of Nanoaggregates, Monolayer Collapse and Prednisolone Spreading. RSC Advances 2017,7(9),5272-5281","journal-title":"RSC Advances"},{"key":"ref=474","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.colsurfb.2017.07.066","volume":"158","year":"2017","unstructured":"Estrada-L&#xF3;pez; Pedreira; Picciani; Oliveira; Pimentel. Interaction of Levofloxacin with Lung Surfactant at the Air-Water Interface. Colloids Surf B Biointerfaces 2017,158,689-696","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=475","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.colsurfb.2018.04.030","volume":"167","year":"2018","unstructured":"Souza; Nascimento; Romeu; Estrada-L&#xF3;pez; Pimentel. Penetration of Antimicrobial Peptides in a Lung Surfactant Model. Colloids Surf B Biointerfaces 2018,167,345-353","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=476","first-page":"207","volume":"26","author":"Baer B.","year":"2018","unstructured":"Baer B.; Veldhuizen E.J.A.; Possmayer F.; Yamashita C.; Veldhuizen R.; The wet bridge transfer system: A novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery. Discov Med 2018,26(144),207-218","journal-title":"Discov Med"},{"key":"ref=477","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.89.3.884","author":"Palmer D.","unstructured":"Palmer D.; Sch&#xFC;rch S.; Belik J.; Effect of Budesonide and Salbutamol on Surfactant Properties J Appl Physiol (1985), 2000, 89(3), 884-890","journal-title":"Effect of Budesonide and Salbutamol on Surfactant Properties J Appl Physiol (1985), 2000, 89(3), 884-890"},{"key":"ref=478","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1128\/AAC.39.2.329","volume":"39","author":"van \u2019t Veen A.","year":"1995","unstructured":"van \u2019t Veen A.; Mouton J.W.; Gommers D.; Kluytmans J.A.; Dekkers P.; Lachmann B.; Influence of pulmonary surfactant on In vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin. Antimicrob Agents Chemother 1995,39(2),329-333","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=479","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1128\/AAC.04937-14","volume":"59","author":"Banaschewski B.J.H.","year":"2015","unstructured":"Banaschewski B.J.H.; Veldhuizen E.J.A.; Keating E.; Haagsman H.P.; Zuo Y.Y.; Yamashita C.M.; Veldhuizen R.A.W.; Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia. Antimicrob Agents Chemother 2015,59(6),3075-3083","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=480","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/930318","volume":"2014","author":"Birkun A.","year":"2014","unstructured":"Birkun A.; Exogenous pulmonary surfactant as a vehicle for antimicrobials: Assessment of surfactant-antibacterial interactions In vitro. Scientifica (Cairo) 2014,2014","journal-title":"Scientifica (Cairo)"},{"key":"ref=481","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.molimm.2009.05.019","volume":"46","author":"van Dijk A.","year":"2009","unstructured":"van Dijk A.; Molhoek E.M.; Veldhuizen E.J.A.; Bokhoven J.L.; Wagendorp E.; Bikker F.; Haagsman H.P.; Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. Mol Immunol 2009,46(13),2465-2473","journal-title":"Mol Immunol"},{"key":"ref=482","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/bip.22250","volume":"100","author":"Haney E.F.","year":"2013","unstructured":"Haney E.F.; Hancock R.E.W.; Peptide design for antimicrobial and immunomodulatory applications. Biopolymers 2013,100(6),572-583","journal-title":"Biopolymers"},{"key":"ref=483","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1039\/C1SM06444D","volume":"8","author":"Wang Y.E.","year":"2012","unstructured":"Wang Y.E.; Zhang H.; Fan Q.; Neal C.R.; Zuo Y.Y.; Biophysical interaction between corticosteroids and natural surfactant preparation: implications for pulmonary drug delivery using surfactant a a carrier. Soft Matter 2012,8(2),504-511","journal-title":"Soft Matter"},{"key":"ref=484","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/1520-6017(200101)90:1<98:AID-JPS11>3.0.CO;2-5","volume":"90","author":"Pham S.","year":"2001","unstructured":"Pham S.; Wiedmann T.S.; Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant. J Pharm Sci 2001,90(1),98-104","journal-title":"J Pharm Sci"},{"key":"ref=485","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-3659(99)00230-8","volume":"65","author":"Wiedmann T.S.","year":"2000","unstructured":"Wiedmann T.S.; Bhatia R.; Wattenberg L.W.; Drug solubilization in lung surfactant. J Control Release 2000,65(1-2),43-47","journal-title":"J Control Release"},{"key":"ref=486","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1164\/ajrccm.159.6.9810047","volume":"159","author":"Herting E.","year":"1999","unstructured":"Herting E.; Gan X.; Rauprich P.; Jarstrand C.; Robertson B.; Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. Am J Respir Crit Care Med 1999,159(6),1862-1867","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=487","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1038\/s41598-017-15558-4","volume":"7","author":"Banaschewski B.J.H.","year":"2017","unstructured":"Banaschewski B.J.H.; Baer B.; Arsenault C.; Jazey T.; Veldhuizen E.J.A.; Delport J.; Gooyers T.; Lewis J.F.; Haagsman H.P.; Veldhuizen R.A.W.; Yamashita C.; The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens. Sci Rep 2017,7(1),15545","journal-title":"Sci Rep"},{"key":"ref=488","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1476-5381.1996.tb16016.x","volume":"119","author":"van\u2019t Veen A.","year":"1996","unstructured":"van\u2019t Veen A.; Mouton J.W.; Gommers D.; Lachmann B.; Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. Br J Pharmacol 1996,119(6),1145-1148","journal-title":"Br J Pharmacol"},{"key":"ref=489","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/jamp.2018.1468","volume":"32","author":"Basabe-Burgos O.","year":"2019","unstructured":"Basabe-Burgos O.; Zebialowicz J.; Stichtenoth G.; Curstedt T.; Bergman P.; Johansson J.; Rising A.; Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model. J Aerosol Med Pulm Drug Deliv 2019,32(2),110-118","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=490","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1128\/IAI.00546-17","volume":"85","author":"Coorens M.","year":"2017","unstructured":"Coorens M.; Banaschewski B.J.H.; Baer B.J.; Yamashita C.; van Dijk A.; Haagsman H.P.; Veldhuizen R.A.W.; Veldhuizen E.J.A.; Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In vivo. Infect Immun 2017,85(12),E17-E546","journal-title":"Infect Immun"},{"key":"ref=491","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1875-9572(10)60042-3","volume":"51","author":"Yang C-F.","year":"2010","unstructured":"Yang C-F.; Jeng M-J.; Soong W-J.; Lee Y-S.; Tsao P-C.; Tang R-B.; Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model. Pediatr Neonatol 2010,51(4),219-226","journal-title":"Pediatr Neonatol"},{"key":"ref=492","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pedneo.2014.04.009","volume":"56","author":"Huang L-T.","year":"2015","unstructured":"Huang L-T.; Yeh T-F.; Kuo Y-L.; Chen P-C.; Chen C-M.; Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice. Pediatr Neonatol 2015,56(1),19-24","journal-title":"Pediatr Neonatol"},{"key":"ref=493","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1164\/ajrccm\/144.4.909","volume":"144","author":"Kharasch V.S.","year":"1991","unstructured":"Kharasch V.S.; Sweeney T.D.; Fredberg J.; Lehr J.; Damokosh A.I.; Avery M.E.; Brain J.D.; Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am Rev Respir Dis 1991,144(4),909-913","journal-title":"Am Rev Respir Dis"},{"key":"ref=494","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1046\/j.1440-1681.2002.03712.x","volume":"29","author":"Nimmo A.J.","year":"2002","unstructured":"Nimmo A.J.; Carstairs J.R.; Patole S.K.; Whitehall J.; Davidson K.; Vink R.; Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clin Exp Pharmacol Physiol 2002,29(8),661-665","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=495","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/hum.1997.8.2-171","volume":"8","author":"Katkin J.P.","year":"1997","unstructured":"Katkin J.P.; Husser R.C.; Langston C.; Welty S.E.; Exogenous surfactant enhances the delivery of recombinant adenoviral vectors to the lung. Hum Gene Ther 1997,8(2),171-176","journal-title":"Hum Gene Ther"},{"key":"ref=496","doi-asserted-by":"publisher","first-page":"L888","DOI":"10.1152\/ajplung.00477.2018","volume":"316","author":"Kothe T.B.","year":"2019","unstructured":"Kothe T.B.; Kemp M.W.; Schmidt A.; Royse E.; Salomone F.; Clarke M.W.; Musk G.C.; Jobe A.H.; Hillman N.H.; Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep. Am J Physiol Lung Cell Mol Physiol 2019,316(5),L888-L893","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=497","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41390-020-0809-6","volume":"88","author":"Hillman N.H.","year":"2020","unstructured":"Hillman N.H.; Abugisisa L.; Royse E.; Fee E.; Kemp M.W.; Kramer B.W.; Schmidt A.F.; Salomone F.; Clarke M.W.; Musk G.C.; Jobe A.H.; Dose of budesonide with surfactant affects lung and systemic inflammation after normal and injurious ventilation in preterm lambs. Pediatr Res 2020,88(5),726-732","journal-title":"Pediatr Res"},{"key":"ref=498","doi-asserted-by":"publisher","first-page":"L193","DOI":"10.1152\/ajplung.00528.2017","volume":"315","author":"Kothe T.B.","year":"2018","unstructured":"Kothe T.B.; Royse E.; Kemp M.W.; Schmidt A.; Salomone F.; Saito M.; Usuda H.; Watanabe S.; Musk G.C.; Jobe A.H.; Hillman N.H.; Effects of budesonide and surfactant in preterm fetal sheep. Am J Physiol Lung Cell Mol Physiol 2018,315(2),L193-L201","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=499","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/pr.2017.171","volume":"82","author":"Ricci F.","year":"2017","unstructured":"Ricci F.; Catozzi C.; Ravanetti F.; Murgia X.; D\u2019Al&#xF3; F.; Macchidani N.; Sgarbi E.; Di Lallo V.; Saccani F.; Pertile M.; Cacchioli A.; Catinella S.; Villetti G.; Civelli M.; Amadei F.; Stellari F.F.; Pioselli B.; Salomone F.; In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration. Pediatr Res 2017,82(6),1056-1063","journal-title":"Pediatr Res"},{"key":"ref=500","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1574884710666150929100210","volume":"11","author":"Roberts J.K.","year":"2016","unstructured":"Roberts J.K.; Stockmann C.; Dahl M.J.; Albertine K.H.; Egan E.; Lin Z.; Reilly C.A.; Ballard P.L.; Ballard R.A.; Ward R.M.; Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials. Curr Clin Pharmacol 2016,11(1),53-61","journal-title":"Curr Clin Pharmacol"},{"key":"ref=501","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ppul.22564","volume":"48","author":"Yang C.F.","year":"2013","unstructured":"Yang C.F.; Lin C.H.; Chiou S.Y.; Yang Y.C.; Tsao P.C.; Lee Y.S.; Soong W.J.; Jeng M.J.; Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant-depleted newborn piglets. Pediatr Pulmonol 2013,48(2),151-159","journal-title":"Pediatr Pulmonol"},{"key":"ref=502","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.33549\/physiolres.932606","year":"2013","unstructured":"P.; MOKR&#xC1;, D.; KOPINCOV&#xC1;, J.; TOM&#x10C;&#xCD;KOV&#xC1;-MIKU\u0160IAKOV&#xC1;, L.; &#x10C;ALKOVSK&#xC1;, A. Budesonide Added to Modified Porcine Surfactant Curosurf May Additionally Improve the Lung Functions in Meconium Aspiration Syndrome. Physiol Res 2013,S191-S200","journal-title":"Physiol Res"},{"key":"ref=503","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1097\/00003246-200111000-00020","volume":"29","author":"Chen C.M.","year":"2001","unstructured":"Chen C.M.; Fang C.L.; Chang C.H.; Surfactant and corticosteroid effects on lung function in a rat model of acute lung injury. Crit Care Med 2001,29(11),2169-2175","journal-title":"Crit Care Med"},{"key":"ref=504","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1203\/00006450-199804000-00018","volume":"43","author":"Fajardo C.","year":"1998","unstructured":"Fajardo C.; Levin D.; Garcia M.; Abrams D.; Adamson I.; Surfactant versus saline as a vehicle for corticosteroid delivery to the lungs of ventilated rabbits. Pediatr Res 1998,43(4 Pt 1),542-547","journal-title":"Pediatr Res"},{"key":"ref=505","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000328928","volume":"82","author":"Dani C.","year":"2011","unstructured":"Dani C.; Corsini I.; Burchielli S.; Cangiamila V.; Romagnoli R.; Jayonta B.; Longini M.; Paternostro F.; Buonocore G.; Natural surfactant combined with beclomethasone decreases lung inflammation in the preterm lamb. Respiration 2011,82(4),369-376","journal-title":"Respiration"},{"key":"ref=506","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/ppul.21145","volume":"44","author":"Dani C.","year":"2009","unstructured":"Dani C.; Corsini I.; Burchielli S.; Cangiamila V.; Longini M.; Paternostro F.; Buonocore G.; Rubaltelli F.F.; Natural surfactant combined with beclomethasone decreases oxidative lung injury in the preterm lamb. Pediatr Pulmonol 2009,44(12),1159-1167","journal-title":"Pediatr Pulmonol"},{"key":"ref=507","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fphys.2020.00266","volume":"11","author":"Das P.","year":"2020","unstructured":"Das P.; Curstedt T.; Agarwal B.; Prahaladan V.M.; Ramirez J.; Bhandari S.; Syed M.A.; Salomone F.; Casiraghi C.; Pelizzi N.; Bhandari V.; Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits. Front Physiol 2020,11,266","journal-title":"Front Physiol"},{"key":"ref=508","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/10717544.2019.1618418","volume":"26","author":"Chen C-M.","year":"2019","unstructured":"Chen C-M.; Chang C-H.; Chao C-H.; Wang M-H.; Yeh T-F.; Biophysical and chemical stability of surfactant\/budesonide and the pulmonary distribution following intra-tracheal administration. Drug Deliv 2019,26(1),604-611","journal-title":"Drug Deliv"},{"key":"ref=509","first-page":"57","volume":"67","author":"Mikolka P.","year":"2016","unstructured":"Mikolka P.; Kopincova J.; Tomcikova Mikusiakova L.; Kosutova P.; Antosova M.; Calkovska A.; Mokra D.; Effects of surfactant\/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. J Physiol Pharmacol 2016,67(1),57-65","journal-title":"J Physiol Pharmacol"},{"key":"ref=510","doi-asserted-by":"publisher","first-page":"S653","DOI":"10.33549\/physiolres.933529","year":"2016","unstructured":"P.; KOPINCOV&#xC1;, J.; KO\u0160&#xDA;TOV&#xC1;, P.; &#x10C;IERNY, D.; &#x10C;ALKOVSK&#xC1;, A.; MOKR&#xC1;, D. Lung Inflammatory and Oxidative Alterations After Exogenous Surfactant Therapy Fortified With Budesonide in Rabbit Model of Meconium Aspiration Syndrome. Physiol Res 2016,S653-S662","journal-title":"Physiol Res"},{"key":"ref=511","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2006-948291","volume":"27","author":"Lewis J.F.","year":"2006","unstructured":"Lewis J.F.; Veldhuizen R.A.; The future of surfactant therapy during ALI\/ARDS. Semin Respir Crit Care Med 2006,27(4),377-388","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=512","doi-asserted-by":"publisher","first-page":"551","DOI":"10.24953\/turkjped.2020.04.004","volume":"62","author":"Heo M.","year":"2020","unstructured":"Heo M.; Jeon G.W.; Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia. Turk J Pediatr 2020,62(4),551-559","journal-title":"Turk J Pediatr"},{"key":"ref=513","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","volume":"121","author":"Yeh T.F.","year":"2008","unstructured":"Yeh T.F.; Lin H.C.; Chang C.H.; Wu T.S.; Su B.H.; Li T.C.; Pyati S.; Tsai C.H.; Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: A pilot study. Pediatrics 2008,121(5),e1310-e1318","journal-title":"Pediatrics"},{"key":"ref=514","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","volume":"193","author":"Yeh T.F.","year":"2016","unstructured":"Yeh T.F.; Chen C.M.; Wu S.Y.; Husan Z.; Li T.C.; Hsieh W.S.; Tsai C.H.; Lin H.C.; Intratracheal Administration of Budesonide\/Surfactant to Prevent Bronchopulmonary Dysplasia. Am J Respir Crit Care Med 2016,193(1),86-95","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=515","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41390-020-0792-y","volume":"88","author":"McEvoy C.T.","year":"2020","unstructured":"McEvoy C.T.; Ballard P.L.; Ward R.M.; Rower J.E.; Wadhawan R.; Hudak M.L.; Weitkamp J-H.; Harris J.; Asselin J.; Chapin C.; Ballard R.A.; Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE). Pediatr Res 2020,88(4),629-636","journal-title":"Pediatr Res"},{"key":"ref=516","doi-asserted-by":"publisher","first-page":"15504","DOI":"10.1038\/ncomms15504","volume":"8","author":"Kronqvist N.","year":"2017","unstructured":"Kronqvist N.; Sarr M.; Lindqvist A.; Nordling K.; Otikovs M.; Venturi L.; Pioselli B.; Purhonen P.; Landreh M.; Biverst&#xE5;l H.; Toleikis Z.; Sj&#xF6;berg L.; Robinson C.V.; Pelizzi N.; J&#xF6;rnvall H.; Hebert H.; Jaudzems K.; Curstedt T.; Rising A.; Johansson J.; Efficient protein production inspired by how spiders make silk. Nat Commun 2017,8,15504","journal-title":"Nat Commun"},{"key":"ref=517","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/sj.bjp.0702405","volume":"126","author":"Van\u2019t Veen A.","year":"1999","unstructured":"Van\u2019t Veen A.; Gommers D.; Verbrugge S.J.C.; Wollmer P.; Mouton J.W.; Kooij P.P.M.; Lachmann B.; Lung clearance of intratracheally instilled 99mTc-tobramycin using pulmonary surfactant as vehicle. Br J Pharmacol 1999,126(5),1091-1096","journal-title":"Br J Pharmacol"},{"key":"ref=518","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41390-019-0663-6","volume":"87","author":"Kothe T.B.","year":"2020","unstructured":"Kothe T.B.; Sadiq F.H.; Burleyson N.; Williams H.L.; Anderson C.; Hillman N.H.; Surfactant and budesonide for respiratory distress syndrome: An observational study. Pediatr Res 2020,87(5),940-945","journal-title":"Pediatr Res"},{"key":"ref=519","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jconrel.2020.11.042","volume":"329","author":"Hidalgo A.","year":"2021","unstructured":"Hidalgo A.; Garcia-Mouton C.; Autilio C.; Carravilla P.; Orellana G.; Islam M.N.; Bhattacharya J.; Bhattacharya S.; Cruz A.; P&#xE9;rez-Gil J.; Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant\/tacrolimus formulations. J Control Release 2021,329,205-222","journal-title":"J Control Release"},{"key":"ref=520","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/5584_2014_64","volume":"839","author":"Kolomaznik M.","year":"2015","unstructured":"Kolomaznik M.; Calkovska A.; Herting E.; Stichtenoth G.; Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin. Adv Exp Med Biol 2015,839,31-39","journal-title":"Adv Exp Med Biol"},{"key":"ref=521","doi-asserted-by":"publisher","first-page":"L41","DOI":"10.1152\/ajplung.00203.2019","volume":"318","author":"Hillman N.H.","year":"2020","unstructured":"Hillman N.H.; Kothe T.B.; Schmidt A.F.; Kemp M.W.; Royse E.; Fee E.; Salomone F.; Clarke M.W.; Musk G.C.; Jobe A.H.; Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep. Am J Physiol Lung Cell Mol Physiol 2020,318(1),L41-L48","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=522","doi-asserted-by":"publisher","first-page":"L949","DOI":"10.1152\/ajplung.00162.2020","volume":"319","author":"Gie A.G.","year":"2020","unstructured":"Gie A.G.; Regin Y.; Salaets T.; Casiraghi C.; Salomone F.; Deprest J.; Vanoirbeek J.; Toelen J.; Intratracheal budesonide\/surfactant attenuates hyperoxia-induced lung injury in preterm rabbits. Am J Physiol Lung Cell Mol Physiol 2020,319(6),L949-L956","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=523","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-01267-8","author":"Hillman N.H.","year":"2020","unstructured":"Hillman N.H.; Kemp M.W.; Fee E.; Rittenschober-B&#xF6;hm J.; Royse E.; Abugisisa L.; Salomone F.; Musk G.C.; Jobe A.H.; Budesonide with surfactant decreases systemic responses in mechanically ventilated preterm lambs exposed to fetal intra-amniotic lipopolysaccharide. Pediatr Res 2020","journal-title":"Pediatr Res"},{"key":"ref=524","doi-asserted-by":"publisher","first-page":"9392","DOI":"10.1038\/s41598-020-66448-1","volume":"10","author":"Baer B.","year":"2020","unstructured":"Baer B.; Veldhuizen E.J.A.; Molchanova N.; Jekhmane S.; Weingarth M.; Jenssen H.; Lin J.S.; Barron A.E.; Yamashita C.; Veldhuizen R.; Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2. Sci Rep 2020,10(1),9392","journal-title":"Sci Rep"},{"key":"ref=525","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00408-020-00399-2","volume":"198","author":"Baer B.","year":"2020","unstructured":"Baer B.; McCaig L.; Yamashita C.; Veldhuizen R.; Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide in vivo. Lung 2020,198(6),909-916","journal-title":"Lung"},{"key":"ref=526","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.33549\/physiolres.933678","year":"2017","unstructured":"J.; MIKOLKA, P.; KOLOMAZNIK, M.; KOSUTOVA, P.; CALKOVSKA, A.; MOKRA, D. Selective Inhibition of NF-KB and Surfactant Therapy in Experimental Meconium-Induced Lung Injury. Physiol Res 2017,S227-S236","journal-title":"Physiol Res"},{"key":"ref=527","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.lfs.2018.04.036","volume":"203","author":"Kopincova J.","year":"2018","unstructured":"Kopincova J.; Mikolka P.; Kolomaznik M.; Kosutova P.; Calkovska A.; Mokra D.; Modified porcine surfactant enriched by recombinant human superoxide dismutase for experimental meconium aspiration syndrome. Life Sci 2018,203,121-128","journal-title":"Life Sci"},{"key":"ref=528","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/molecules24050905","volume":"24","author":"Kopincova J.","year":"2019","unstructured":"Kopincova J.; Kolomaznik M.; Mikolka P.; Kosutova P.; Topercerova J.; Matasova K.; Calkovska A.; Mokra D.; Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome. Molecules 2019,24(5),905","journal-title":"Molecules"},{"key":"ref=529","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0079-6107(68)90019-9","volume":"18","author":"Bangham A.D.","year":"1968","unstructured":"Bangham A.D.; Membrane models with phospholipids. Prog Biophys Mol Biol 1968,18,29-95","journal-title":"Prog Biophys Mol Biol"},{"key":"ref=530","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"Allen T.M.","year":"2013","unstructured":"Allen T.M.; Cullis P.R.; Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013,65(1),36-48","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=531","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/IJN.S26766","volume":"7","author":"Chang H-I.","year":"2012","unstructured":"Chang H-I.; Yeh M-K.; Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 2012,7,49-60","journal-title":"Int J Nanomedicine"},{"key":"ref=532","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"Bozzuto G.","year":"2015","unstructured":"Bozzuto G.; Molinari A.; Liposomes as nanomedical devices. Int J Nanomedicine 2015,10,975-999","journal-title":"Int J Nanomedicine"},{"key":"ref=533","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012","volume":"9","author":"Bulbake U.","year":"2017","unstructured":"Bulbake U.; Doppalapudi S.; Kommineni N.; Khan W.; Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 2017,9(2)","journal-title":"Pharmaceutics"},{"key":"ref=534","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1089\/jamp.2008.0686","volume":"21","author":"Li Z.","year":"2008","unstructured":"Li Z.; Zhang Y.; Wurtz W.; Lee J.K.; Malinin V.S.; Durwas-Krishnan S.; Meers P.; Perkins W.R.; Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. J Aerosol Med Pulm Drug Deliv 2008,21(3),245-254","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=535","unstructured":"FDA Approves a New Antibacterial Drug to Treat a Serious Lung Disease Using a Novel Pathway to Spur InnovationAvailable from: FDA Https:\/\/Www.Fda.Gov\/News-Events\/Press-Announcements\/Fda-Approves-New-Antibacterial-Drug-Treat-Serious-Lung-Disease-Using-Novel-Pathway-Spur-Innovation","journal-title":"FDA Approves a New Antibacterial Drug to Treat a Serious Lung Disease Using a Novel Pathway to Spur InnovationAvailable from:"},{"key":"ref=536","author":"Sirimanne M.D.","year":"2020","unstructured":"Sirimanne M.D.; Patel J.A.; Kankam M.; Vince B.D.; Turkel C.C.; A Randomized Phase 1 Safety Study of Repeated Doses of Intranasal OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adults: A Potential Treatment for Otitis Media. BMC Pharmacology and Toxicology, 2020","journal-title":"BMC Pharmacology and Toxicology,"},{"key":"ref=537","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1089\/jamp.2010.0855","volume":"24","author":"Geller D.E.","year":"2011","unstructured":"Geller D.E.; Weers J.; Heuerding S.; Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere\u2122 technology. J Aerosol Med Pulm Drug Deliv 2011,24(4),175-182","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref=538","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jconrel.2015.03.015","volume":"206","year":"2015","unstructured":"De Backer; Braeckmans; Stuart; Demeester; De Smedt; Raemdonck. Bio-Inspired Pulmonary Surfactant-Modified Nanogels: A Promising SiRNA Delivery System. J Control Release 2015,206,177-186","journal-title":"J Control Release"},{"key":"ref=539","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.actbio.2018.08.012","volume":"78","author":"Surfactant Protein B.","year":"2018","unstructured":"Surfactant Protein B.; (SP-B) Enhances the Cellular SiRNA Delivery of Proteolipid Coated Nanogels for Inhalation Therapy. Acta Biomater 2018,78,236-246","journal-title":"Acta Biomater"},{"key":"ref=540","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040775","volume":"7","author":"Ruge C.A.","year":"2012","unstructured":"Ruge C.A.; Schaefer U.F.; Herrmann J.; Kirch J.; Ca&#xF1;adas O.; Echaide M.; P&#xE9;rez-Gil J.; Casals C.; M&#xFC;ller R.; Lehr C.M.; The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=541","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.nano.2011.07.009","volume":"7","author":"Ruge C.A.","year":"2011","unstructured":"Ruge C.A.; Kirch J.; Ca&#xF1;adas O.; Schneider M.; Perez-Gil J.; Schaefer U.F.; Casals C.; Lehr C.M.; Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 2011,7(6),690-693","journal-title":"Nanomedicine"},{"key":"ref=542","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1080\/10717544.2017.1402217","volume":"24","author":"Li N.","year":"2017","unstructured":"Li N.; Weng D.; Wang S-M.; Zhang Y.; Chen S-S.; Yin Z-F.; Zhai J.; Scoble J.; Williams C.C.; Chen T.; Qiu H.; Wu Q.; Zhao M.M.; Lu L.Q.; Mulet X.; Li H.P.; Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury. Drug Deliv 2017,24(1),1770-1781","journal-title":"Drug Deliv"},{"key":"ref=543","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fmed.2018.00018","volume":"5","author":"Sorensen G.L.","year":"2018","unstructured":"Sorensen G.L.; Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Front Med (Lausanne) 2018,5,18","journal-title":"Front Med (Lausanne)"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666210825110421","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195828\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666210825110421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T10:37:14Z","timestamp":1673260634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195828\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":543,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666210825110421","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}